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GENERAL INTRODUCTION 
Since the fIrst successful orthotopic cardiac transplantation in 1967. the survival after 
transplantation has gradually been improved due to the introduction of cyclosporin-A, the 
monitoring of acute rejection by cndomyocardial biopsies and optimized patient carel, In the 
last decade, clinical studies indicate that coronary artcry disease ill the graft is the most 
common cause of death in the first postoperative years2-.l, The earliest change consist of 
concentric fibrosis and smooth muscle cell proliferation with collagen accumulation 
creating diffuse intimal thickening. Tills process involves not only the large epicardial 
vessels but also the intramyocardial branches5, The specific fillgiographic morphology of the 
lesions found after transplantation was described by the group of Stanford, distinguishing 3 
categories: type A, discrete or short tubular stenosis in the proximal, middle or distal 
segments of major coronary arteries or their branches, type B; diffuse concentric luminal 
narrowing in the middle to distal segment branches; and type C, diffusely nalTowed irregular 
distal branches that are squared of and end abl1lptly, the latter two groups both unique to the 
post-transplant patients6• Despite this clear categorization, pathological examinations 
showed that the process of accelerated coronary artelY disease is underestimated by visual 
interpretation of coronmy angiography7. Thus, visual interpretation of coronary angiography 
has limitations for both clinical and research purposes. 
The aim of this thesis is to describe the changes in the coronary vasculature in the first 
six years after cardiac transplantation and to correlate these changes with previously 
identified risk factors. In addition to morphological epicardial coronary artery changes, 
assessed by quantitative coronary angiography, myocardial flow reserve and atrial pacing 
stress were used to assess the influence of accelerated coronary artery disease on myocardial 
flow and cardiac function. Chapters II-V describe the results of quantitative analysis of 
serial coronary angiograms at different postoperative stages. The influence of changes in 
coronary microvasculature on myocardial flow reserve is described in chapters VI and VII. 
Chapter VIII describes the functional correlates of diffuse coronary artelY disease using 
atrial pacing stress at the time of routine angiography. 
QuantitatiYe corol131'Y angiography 
Coronary angiography has been used as a diagnostic tool for more than 30 years. In the 
last decade the introduction of computer assisted analysis provided a more objective and 
reproducible method to describe the changes in the coronary luminal diameter. This 
technique has evolved to be the oplimalmethod to study coronary artery dimensions in trials 
concerning the progression and regression of coronary artery diseaseR. 
The computer-assisted Cardiovascular Angiography Analysis System (CAAS) has been 
in operation at the Thoraxcenter since 1982. The boundaries of a selected coronary segment 
are detected automatically from optically magnified regions of interest (512 x 512 pixels) of 
an end diastolic cineframe. The mean, minimal and maximal coronary width of each 
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segment are calculated in millimetres. 
Two parameters are used in tlus thesis to describe the progression or regression of diffuse 
coronary artery disease. The patient global score, a description of the coronary status of an 
individual patient, is used to describe progression or regression of diffuse caron my artery 
disease. In addition, the minimal segment width is measured to assess development ofJocal 
diseases. 
Myocardial flow reserve 
The concept of myocardial flow reserve has been developed as a means to describe the 
functional capacity of a coronary artery i.e. the relationship between the angiographic 
severity of coronary artery disease and the resulting limitation in maximal myocardial blood 
flow9 • In theory, tIus is especially relevant in cardiac transplant recipients, where a diffuse 
arteriopathy involving the microvasculature, can reach a flow limiting significance, without 
changes in the angiographic appearance. Several techniques are currently under 
development to allow the assessment of myocardial flow reserve in humans. In general, 
these techniques are designed for application during a catheterization procedure, like venous 
blood flow measurements in the coronary sinus, or the assessment of phasic coronary blood 
flow velocities using ultrasonic Doppler catheters9•1O• 
Early studies concerning the calculation of coronary blood flow by analysis of contrast 
passage in the coronary arteriogram were reported almost 25 years ago ll • Analysis of these 
changes in contrast density, delineation of so-called time-density curves and subsequent 
calculation of time parameters from these curves, was referred to as videodensitometry. 
Shortly thereafter it was shown that visualisation of contrast agent through the myocardium 
could be enhanced by ECG-triggered subtraction imaging. If digital methods are used for 
this purpose, the term digital radiography is applied. Compared with the other invasive 
techniques to measure myocardial flow, this approach has several advantages. First, the 
technique is lllore easily applicable during routine catheterization, because no additional 
catheter or intracmonary device has to be used. Moreover, the analysis of multiple regions 
of interest provides flow information from various subsegments of the coronmy artery trec, 
which is not possible or more time consuming with other invasive techniques. 
Atrial pacing stress test 
In patients with coronary artery disease a narrowing of the vasculature can lead to 
subnormal perfusion of specific regions of the myocardium, with decreased mechanical 
function. A reduction in global myocardial function may not become manifest except during 
physical activity or other types of stress. Atrial pacing as a stress test to investigate the 
dynamic response of the heart in these patients was introduced as attractive method13• 
Advantages of this method are the rapid reversibility, its precise control in both duration and 
cardiac frequency, and the removal of psychological factors, since the patient is unaware of 
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the precise level of stress. Atrial pacing increases myocardial oxygen consumption by means 
of an increase in heart rate and augmented wall stress. Hemodynamic measurements at peak 
pacing reveal differences in left ventricular end-diastolic pressure, peak positive rate of 
isovolumic left ventricular pressure rise and calculated maximal myocardial velocity of 
shortening in patients with coronary artery disease as compared to controls 13 • We therefore 
used the atrial pacing stress test to verify its application in early detection of the diffuse 
coronary artery disease as present in cardiac transplant recipients. 
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INTRODUCTION 
Coronary arteriosclerosis of the cardiac allograft is the leading cause of morbidity and 
mortality in late survivors (> 1 year) after cardiac transpluntation'-J. In order to detect the 
onset and progression of allograft coronary disease, most transplant centers perform 
COIOOalY cine-angiography at regular intervals after transplantation. Allgiographycally there 
is typically diffuse lumillalnalTowing with distal vessel obliteration. Accordingly this type 
of coronary disease is usually not amendable to balloon angioplasty or bypass graft surgcryt. 
In addition to diffuse disease, however, some cardiac transplant recipients may develop 
more sbarply demarcated lesions. In our series of 200 patients receiving an orthotopic 
cardiac transplant from June 1984 to January 1993 one year survival was 92%, confidence 
interval 88-96%5. Five patients underwent a balloon dilatation or atherectomy for localized 
coronary stenosis. The rate of progression of focal and diffuse disease in these patients was 
studied by quantitative analysis of sequential coronary angiograms using an automated 
contour detection technique6• 
CASE REPORTS 
A 37-year-old man (patient A) underwent cardiac transplantation in January 1985 
because of end stage heart failure, due to dilated cardiomyopathy. He received a donor heart 
from a 34-year-old woman (Table I). Immunosuppressive therapy consisted of cyc1osporine 
and low dose steroids. After transplantation he experienced several upper airway infections. 
The patient resumed smoking. One episode of acute rejection was treated with 
methylprednisolone. In the first postoperative years, the serum cholesterol level averaged 
Table 1. Risk factors 
Patient A B C D E 
Age recipient (years) 37 28 50 46 55 
Age donor (years) 33 26 35 36 34 
Gender mismatch yes yes no no no 
Number of HLA mismatches 3 4 3 4 6 
Number of rejection episodes I 6 2 2 3 
Smoking yes no yes no no 
Serum Cholesterol (mmolll) 5.9 6.0 8.4 7.6 9.0 
Serum HDL-Cholesterol (mmoYI) 1.8 1.5 1.2 1.2 2.3 
SelUm Triglyceride (mIDoYI) 1.4 1.8 3.7 3.3 1.9 
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5.9 mlllolll. Focal luminal narrowing in the left circumflex (LeX) coronaty artery was 
observed on the third annual coronary angiogram. In the fifth postoperative year a 50-60% 
stenosis had developed (Figure I). Since "'·Tc methoxyisobutyl isonitrile (MIB!) perfusion 
scintigraphy showed reversible ischemia of the left ventricular posterior wall, a 
percutaneous coronary intervention was scheduled. Directional coronary atherectomy was 
performed, because of the eccentricity of the lesion. The angiograms before and after the 
intervention are shown in figure 1. At follow-up, 7 months later, no restenosis was visible. 
Quantitative analyses of three visually "normal" segments of tIlis patient are shown in figure 
2. Although there is considerable variation over the years, no significant diffuse luminal 
narrowing of these segments could be detected. At 6 year follow-up, the perfusion 
scintigraphy showed reversible ischemia of the anterior wall. Coronary angiography 
revealed diffuse wall ilTegularities and aneurysmal dilatation of the left anterior descending 
branch. One year later, seven and a half years after transplantation, at a meeting of cardiac 
transplant recipients, he collapsed because of a cardiac arrest. He underwent successful 
cardiopulmonary resuscitation. In the hospital no electrocardiograpllic signs of myocardial 
infarction or elevated plasma levels of creatine kinase were detected. His cardiac arrest was 
probably related to reversible ischemia of the myocardium resulting in a ventricular 
arrythmia. A few days later he was declared brain death and the ventilatory support was 
tenllinated. 
Figure 1. Quantitative analysis of the obstruction in the middle segment of left circumflex coronary 
artery of patient A, filmed both before and after atherectomy. The white area is a measure of the 
atherosclerotic plaque and is derived form the actual luminal contour and a interpolated reference 
contour. Reprinted by penllission of the American Heart Journal, Strif....rerda S, Umans V, Hm del' 
Lilldelll\1MJ1\1, Hm Suylen RJ, Balk AHMM, De Fey tel' PJ, 5ierruys pn~' vollime 123: pp 1686-
1690, 1992. Copyright 1992. All rights resen'ed. 
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The second patient (patient B) was a 28-year-old woman, who developed postpartum 
cardiomyopathy after the birth of her second child in June 1985. Iu April 1986 she received 
the heart of a 26-year-old man. There were six acute rejection episodes, which were treated 
with pulsed doses of methylprednisolone. and polyclonal and monoclonal anti-T-cell 
antibodies. Because of ongoing rejection. azathioprine was added to her maintenance 
immunosuppressive therapy consisting of cyclosporine and prednisolone. Hypertension was 
present, which was treated with nifedipine. The mean serum cholesterol level after 
transplantation was 6.0 mllloUl, and mean high density lipoprotein cholesterol and 
triglyceride levels were 1.5 and 1.8 mmoll1, respectively. On the third annual angiogram, a 
50% stenosis iu the left anterior descending (LAD) coronary artelY was detected just distal 
to a large diagonal side branch. One year later, this stenosis had progressed to approximately 
80% diameter reduction. 99mTc MIBI perfusion scintigraphy showed evidence of reversible 
ischemia of the anteroseptal and anterior myocardium and a balloon dilatation was 
pelfonned successfully. At 5 year follow-up angiography. no restenosis of the culprit lesion 
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Figul'e 2. Change in mean diameter of the proximal obtuse marginal branch (MO), proximal left 
anterior descending (LAD) coronary artery, and posterior lateral branch (PL) after cardiac 
transplantation in patient A, averaged after quantitative analysis in mUltiple matched views, relative 
to the fIrst year angiograms in millimetres. A change in diameter exceeding twice the long-teon 
variability of our quantitative angiography systemS (0.72 lllm), represented by the two horizolltal 
lines, was considered a significant change from baseline, taking into account that the fust coronary 
angiograms were not acquired under standard conditions, i.e. no special care was taken to reduce the 
potential sources of variability (X-ray system settings and vasomotor tone). 
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was found. However, other segments of the coronary tree showed progression of both 
diffuse and focal coronary disease. Sbe died five and a half years after transplantation from 
severe beart failure due to ischemia of the myocardium. 
The third patient (patient C) was a 50-year-old man, who developed cardiomyopathy as 
a result of alcoholism. In 1989 he received the heart of a 35 year old man. This patient 
suffered from two episodes of acute rejection in the fIrst year after transplantation. The mean 
serum cholesterol level averaged 8.4 mmolli. In the first postoperative year he resumed 
smoking. Coronary angiography after one year revealed normal epicardial coronary arteries. 
Minor wall irregularities were seen of tbe smaller septal branches. After two years a focal 
stenosis was seen of the LAD « 50% by visual assessment), which showed progression in 
the subsequent years and was treated by directional coronary atherectomy in 1993 because 
of angina and electrocardiographic signs of ischemia. The disease of the smaller branches 
did not increase in severity. In 1994 has was readmitted because of a small inferior 
myocardial infarction (peak plasma level of creatine kinase 363 U/I). Coronary angiography 
revealed a closure of the proximal right coronary artery. The treated lesion in the LAD only 
showed minor wall inegularities. In february 1996 99mTc MillI perfusion scintigraphy 
showed no evidence of reversible ischemia. Echocardiography revealed a decreased left 
ventricular function. In July 1996 coronary angiography showed no additional focal 
coronary lesions. In august 1996, almost 8 years after transplantation, he was admitted to the 
hospital with signs of heart failure and died a few weeks later. 
The fourth patient (patient D) was a 46-year-old man, who underwent cardiac 
transplantation because of ischemic heart disease. In 1987 he received the heart of a 36 year 
old man. Within a few weeks after hospital discharge he was readmitted because of acute 
rejection. He suffered from another episode of acute rejection in the fourth postoperative 
year. Annual coronary angiography revealed diffuse coronaty artery disease within two 
years after transplantation. After fIve years two focal lesions developed in the left anterior 
descending branch, which were treated by directional atherectomy. Recently, a coronary 
angiography was performed which showed a significant stenosis distal in the left anterior 
descending branch and diffuse wall in-egularitics of all coronary artelY branches. Since a 
99mTc MIBI perfusion scintigraphy did not show signs of ischemia, an intervention was not 
performed. At tills moment, 9 years after transplantation, he is in excellent condition. He 
resumed working and does not have any complaints. 
The fIfth patient (patient E) was a 55-year-old woman. In 1988 she received the heart of 
a 34 year old woman. Annual coronaty angiography revealed only minor wall irregularities 
of the small septal branches of the LAD, willch did not increase in severity. She was treated 
for mild hypertension with nifedipine from the first postoperative year. The serum 
cholesterol level averaged 9.5 lllmolll and mean high density lipoprotein cholesterol and 
triglyceride levels were 1.89 and 2.30 mmol/I, respectively. In the fourth postoperative year 
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she was admitted to the hospital because of an acute anterior myocardial infarction. 
Coronary angiography revealed waH ilTegularities in all major epicardial vessels and all 
smaller branches of the coronary tree. Furthermore, the coronary angiogram showed a 
significant stenosis (>50% stenosis) of the LAD, which was treated by balloon angioplasty. 
In 1994, 6 years after transplantation, a 99mTc MIBI perfusion scintigraphy showed signs of 
ischemia, and a coronary angiography was repeated. Severe coronmy atherosclerosis was 
seen with significant stenoses in the proximal and distal segments of the right coronary 
artery, and proximal and distal segments of both the circumflex and anterior descending 
branch of the left coronary artery. Before the results of this coronary angiogram could be 
discussed by the cardiologists of the transplant team and the surgeons, she died. 
DISCUSSION 
The pathogenesis of accelerated coronary artery disease in cardiac transplant recipients 
remains unclear. It is thought, however, that an immune-mediated insult to the vascular 
endothelium initiates the process, since it affects the coronal)' arterial system over its entire 
length. Diffuse intimal hyperplasia, due to smooth muscle cell proliferation and 
accumulation of collagen in a circumferential distribution, has been observed as early as I 
week after transplantation8.". A progressive rise in the degree of luminal narrowing and a 
greater proportion of focal, eccentric plaques have been observed as a function of allograft 
survival time8 • Once the initial injury to the coronary endothelium has occurred, other 
factors may influence the rate of development and the morphologic feahlres of both diffuse 
and focal transplant coronary lesions. In particular, accelerated coronary artery disease has 
been reported to be associated with the occurrence of HLA incompatibilities l , acute rejection 
episodesD , higher donor age1,lO, elevated serum triglyceride levels l ,lO, elevated total 
cholesterol and low density lipoprotein levels3 and Cytomegalo virus infections". Gao et a1. 
compared concentrations of sennll lipids in patients with the morphologic type of coronary 
artery disease on the coronary angiogram. Surprisingly, a greater association of higher 
triglyceride and total cholesterol levels was found with diffuse concentric distal obliterative 
lesions than with more focal discrete disease located in proximal and middle portions of 
vessels". In our series we could not find any relation between either focal or diffuse disease 
and these risk factors('.ll. 
As in these case reports, most patients show no lumen abnormalities on their first year 
angiogram at the site of subsequent obstruction. Progression of focal coronary artery disease 
appears to be as rapid and unpredictable as native coronary atherosclerosis13• It should be 
appreciated that coronary arteriography is relatively insensitive for detection of early 
vascular lesions!4. In particular, focal lesions graded as having <25% diameter nalTowing on 
microscopic examination and diffuse disease are often underdiagnozed by coronary 
angiographyl\ even when (semi)quantitative techniques are uscd 15. 
In ollr series of 293 cardiac transplant recipients 9 patients underwent a coronary 
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intervention (directional atherectomy or balloon angiopIasty) because of significant stenoses 
of the coronary artery tree with evidence of reversible ischemia on 99mTc MIBI perfusion 
scintigraphy. 
Histologic examination of the coronary atherosclerosis specimen retrieved by 
atherectomy in patient A revealed a velY interesting finding. The tissue had a low-to-
moderate cellularity, embedded in collagen bundles and cellular matrh:, resembling ordinary 
atherosclerotic plaque!6. Results from a polymerase chain reaction analysis of variable 
number of tandem repeat (VNTR) gene loci showed that the coronary arteriosclerotic tissue 
of patient A and donor myocardial biopsy performed immediately after transplantation 
shared the same alleles and that this pattern consistently differed from that of the recipients 
blood17. These findings support the concept that focal lesions in graft atherosclerosis may 
represent progression of preexisting though angiographically undetectable coronary disease 
of the donor heart. However, these observations do not exclude the possibility of accelerated 
development of a de novo "ordinary" atherosclerotic plaque after cardiac transplantation. 
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ABSTRACT 
In order to evaluate the changes in coronary luminal morphology in cardiac transplant 
recipients, serial quantitative coronary angiography was performed 1 month and 1 year after 
transplantation in 30 patients. Between 6 and 8 segments of the coronary artery tree were 
analyzed in multiple matched projections using an automated edge detection technique. 
Twenty-fivc patients were treated with calcium-channel blockers. 
The mean segment diameter of the 249 analyzed segments showed a small decrease from 
3.40 ± 0.82 mm at I month to 3.36 ± 0.83 mm at I year (p=O.007). Twelve patients (40%) 
showed luminal narrowing, using the variability of the analysis system (0.11 mm) as a cut 
off level for significance. In 12 other patients (40%), coronmy luminal diameter did not 
change, and in 6 patients (20%) an increase in diameter was found. Patients, transplanted 
because of severe coronary artel)' disease showed a larger reduction in lumen diameter than 
patients with other indications for transplantation. No other risk factors for reduction of 
coronary artery diameter were identified. This study using quantitative analysis of coronary 
angiogrmns confirms the minimal reduction in diameter of epicardial arteries in the first year 
after transplantation in patients lIsing calcium-channel blockers. 
INTRODUCTION 
Accelerated coronary artery disease is one of the limiting factors for long term survival 
of cardiac transplant recipients!. Due to the lack of innervation of the cardiac aUograft, 
angina pectoris is usually absent, and electrocardiographic signs of myocardial infarction, 
congestive heart failure or sudden death may be the first signs of graft coronary 
arteriosclerosis1• 
In order to detect the onset and progression of coronary disease in an early phase, 
coronary arteriography is performed yearly in many transplant centers. The reported 
incidence of visually detectable coronary artery disease varies considerably, ranging from 2 
to 34 % at I year, and from 50 to 73 % at 6 years after transplantation3-11 • This study was 
undertaken to provide a more accurate and objective evaluation of the development of 
coronalY artery disease in the first postoperative year by quantitative analysis of large 
epicardial coronary branches filmed both I month and 1 year after transplantation. Also, the 
relation between such changes and potential risk factors for transplant atherosclerosis 12·11 
was explored. 
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PATillNTS AND METHODS 
Patients 
From September 1989 until September 1990 thirty-one patients underwent cardiac 
transplantation at the Thoraxcenter. Early coronary angiography was performed in 30 
patients to establish initial coronary status after transplantation. All 30 patients underwent 
follow-up angiography 1 year after transplantation. One other patient died 2.5 months after 
transplantation from multi-organ failure. 
Early prophylactic immunosuppressive therapy consisted of 7 day courses of polyclonal 
(Horse anti-thymocyte globulin, antilymphocyte IgG2, Lymphoglobulin, Institute Merieux) 
or monoclonal anti-Teen antibodies (OKT3. Ortho Pharmaceutical, Raritan, N.J.) in 15 
patients eachB. :Maintenance imlllunosuppression consisted of Imv dose steroids and 
cyclosporine. Additional immunosuppressive treatment was instituted in cases of moderate 
rejection with definite myocyte necrosis (Bi11ingham grade 2)24, and consisted of pulsed high 
dose steroids and poly- or monoclonal allti-T cell therapy. In 5 patients, azathioprine was 
added to the maintenance regimen because of ongoing or recurrent rejection. 
Cytomegalo virus (CMV) seronegative recipients received allti-CMV 
hyperimll1l1noglobulin (Cytotect, Biotest Pharma GmbH, Dreiech, Germany) during the first 
10 weeks after trallsplantationH • CMV infection was defined as any rise in serum Ig:M, 
isolation of CMV from urine, throat or buffycoat, or evidence of CMV immediate early 
antigen. CMV disease was defined as infection accompanied with fever >38°C for at least 2 
days, and either leukocytopenia « 2.5 x 10"'/1) or thrombocytopenia (<l00 x 10'/1), or 
symptoms of organ involvement15. 
All patients were managed with anti platelet agents, consisting of either dipyridamole 75 
mg tid or aspirin 80 mg daily. Hypertension was prcfernbly treated with nifedipine. 
Quantitative coronary angiography 
All patients underwent left heart catheterization and selective coronary angiography, 
using the femoral approach. To reduce variations in dynamic vessel tone, 5 mg of 
isosorbide-dinitrate was administered sublingually before the first coronary contrast 
injection. 
The coronary angiograms were analyzed by automated edge detection, using the 
computer based Cardiovascular Angiography Analysis System (CAAS), which has been 
described in detail previouslyZ6.2J. An example of an analysis is shown in figure 1. The 
variability of the contour detection system, defined by the standard deviation of the 
differences of the computed results from repeated analyses, is 0.11 HUll for the mean width 
in non-obstructed segments27. Progression of coronary artery narrowing was defined as a 
decrease of segment width by more than 0.11 mm12. At baseline and follow-up coronary 
angiography, nine proximal coronary segments were measured in multiple matched 
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Figure 1. Quantitative analysis of the proximal right coronary artery of a 48 year old cardiac 
transplant recipient, one year after cardiac transplantation. A single frame of the angiogram is shown 
with superimposition of the contours, as traced by the automated contour detection system. 
projections: segments 1-3,5,6-8, 11 and 13 or 14 according to the classification by the 
American Heart Association2S • 
The results of present study are expressed in a patient global score and a segment global 
score as described earlierl~. Patient global score was defIned as the average of the mean 
widths of the measured segments per patient. The patient global score change was defined 
as the average change in the mean width of the segments. The segment global score was 
defined as the average of mean widths of all measured segments. 
Statistical analysis 
All data are presented as the mean ± 1 SD. Statistical analysis of the change in coronary 
diameter was performed using the Wilcoxon Matched-pairs Signed-ranks test. Logistic 
regression and chi square tests were used to identify risk factors for accelerated coronary 
artery disease. Statistical significance was defined as a p value of 0.05 or less. 
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Table 1. Clinical data of the cardiac transplant recipients 
Recipient age (yrs) 
Donor age (yrs) 
Gender 
Gender mismatch (pts) 
Heart disease 
HLA-mismatch 
Cold ischemia time (min) 
Rejection episodes (no, median) * 
No of patients with 
Cholesterol (mlllolll) t 
Triglycerides (n1lHoll!) t 
HDL-cholesterol (n1lnolll) t 
Smoking (yes 1 no) * 
Hypertension (150/95 mmHg) (pts) 
Blood pressure 
Diabetes Mellitus (pts) 
CMV preop serostatns neg (pts) 
CMV infection (pts) 
CMV disease (pts) 
Use of nifedipine (pts) * 
CMP 
IHD 
VHD 
A (no) 
B 
DR 
OAR* 
lAR 
2AR 
Systolic (mmHg) § 
Diastolic (mmHg) 
F:female; M:male; CMP:cardiomyopathy; IHD:ischemic heart disease; 
VHD:valvular heart disease; AR:acute rejection; 
HDbHigh Density Lipoproteins; CMV=Cytomegalo vims; 
* between 1 month and I year follow-up; t mean value in the first year 
after transplantation; * during the first postoperative year; 
§ at follO\v-up catheterization 
30 
45 ± 12 
26 ± 8 
2F,28M 
9 
14 
14 
2 
1.4 ± 0.6 
1.6 ± 0.5 
1.3 ± 0.6 
154 ± 30 
I (range 0 - 4) 
12 
14 
4 
7.4 ± 1.7 
2.3 ± 0.8 
1.5 ± 0.5 
7/23 
22 
141 ± 20 
90 ± 11 
2 
13 
12 
7 
25 
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RESULTS 
The clinical data of these 30 cardiac transplant recipients are described in table 1. In 29 
patients early corouroy angiography was performed at a median of 34 days after 
transplantation (range 19 - 109 days), In one patient, who suffered from reCUlTcnt rejection 
episodes, the first angiogram was made 6 months after transplantation. Follow-up coronary 
angiography was pctformed at a median of 12.2 months after transplantation (range 10.7 -
13.1mollths). 
In total 249 segments were available for paired quantitative measurement. In 2 patients 
6 segments were analyzed. in 1 patient 7 segments, in 13 patients 8 segments and in 14 
patients 9 segments. The length of the selected coronary segments averaged 21.2 ± 9.3 lllill 
in the early angiogram and 21.1 ± 9.4 mm at follow-up (difference not statistically 
significant). 
Patient global score 
Patient global score was similar at 1 month and I year after transplantation, respectively 
3.39 ± 0.34 and 3.35 ± 0.34 Illlll. If the variability of the CAAS system, O.ll Illlll, is applied 
Table 2. 
change (llllll) 
< -O.ll 
-O.ll - +O.ll 
> +O.ll 
total 
Table 3. 
Change in patient global score 
Humber of patients 
12 
12 
6 
30 
Segment global score by vessel size 
mean ± SD (mill) 
-0.23 ± 0.10 
-0.01 ± 0.07 
0.25 ± 0.11 
-0.05 ± 0.20 
Segment mean width number of segment global score (mm) change in segment global score 
al baseline (nun) segments baseline I year absolUie (mm) relatire (%) 
>3.77 83 4.29 ± 0.38 4.19±0.48 ·0.10 ± 0.38 -2.3 ± 9.0 p=O.OI 
3.07 - 3.77 83 3.43 ± 0.21 3.40 ± 0.39 ·0.03 ± 0.33 ·0.9 ± 9.4 NS 
< 3.07 83 2.48 ± 0.43 2.48 ± 0.47 ·0.00 ± 0.23 0.2 ± 9.1 NS 
total 249 3.40 ± 0.82 3.36 ± 0.83 ·0.05 ± 0.32 ·1.0±9.2 p=O.007 
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Table 4. Change in segment global score change 
diameter change number of change in segment global score 
(mill) segments absolute (n1ln) relative (%) 
< -0.11 105 -0.32 ± 0.18 -9.0 ± 4.2 
-0.11-0.11 75 -0.02 ± om -0.6 ± 2.3 
> 0.11 68 0.34 ± 0.21 10.7 ± 6.1 
total 248 -0.05 ± 0.32 -1.0 ± 9.2 
as a cut off level for significance, 12 patients (40%) showed luminal nalTOWillg. In 12 
patients (40%) coronary luminal diameter did not change, and in 6 patients (20%) an 
increase was found (Table 2), 
Segment global score 
Comparison of segment global score 1 and 12 months after transplantation (Table 3), 
showed small decrease from 3.40 ± 0.82 to 3.36 ± 0.83 mm (p=O.OO7). The mean relative 
reduction of segment diameter was 1.0 %. This reduction in segment global score proved to 
be statistically significant only for vessel-segments larger than 3.77 mm (Table 3). The 
smaller segments did not show any reduction of segment diameter. Based on the variability 
of the CAAS system, 105 segments showed luminal narrowing, 75 segments did not change, 
and in 69 segments luminal diameter increased (Table 4) .. Minimal segment diameter of all 
249 segments decreased from 2.97 ± 0.83 to 2.92 ± 0.S41l1111 (p=O.OI). a reduction of 1.5 %. 
Risk factors 
Patients, with coronary artery disease prior to cardiac transplantation (N;:::14), showed a 
reduction of patient global score in contrast with patients with other indications for 
transplantation (-0.13 ± 0.17 mm versus 0.03 ± 0.20 1ll1l1, p<0.05). Using the 0.11 nun 
threshold as a cut of level for significance, tltis indication related risk could not be confirmed 
by chi square test. No other risk factors for reduction of corollalY artery diameter (Table 1) 
were identified. 
DISCUSSION 
In the present study of 30 consecutive patients only minimal changes in coronalY 
diameter were apparent. TillS is in contrast with a distinct reduction of coronary artery 
32 CHAPTER 3 
diameter (-0.23 ± 0.19 nun) as reported in 25 patients dnring the first postoperative year at 
Stanford11• The present data are in agreement with subsequent data from Stanford13 in 
patients treated with the calcium-channel blocker diltiazem. 
Assessment of transplant coronary artery disease 
Transplant coronary artery disease is a major problem affecting long term survival of 
cardiac transplant recipients. Publications from various transplant centers and the registry 
from the International Society for Heart and Lung Transplantation show that over 40% of 
all deaths after the first postoperative year are caused by this disease. Various methods and 
definitions to determine the onset or progression have been used3•12,29-3I, It should be 
appreciated that customary visual interpretation of the coronary angiograms underestimates 
the degree and extent of this process3l • Histologic evidence of minimal coronary artery 
disease is present in all patients who die 1 year or later after transplantation, independent of 
the cause of death and the interval after transplantation3")!. These pathological findings were 
confirmed by in vivo intracoronary ultrasound in cardiac transplant recipients3233• 
Nevertheless angiographic evidence of accelerated coronary disease is reported in only 2 to 
34% at one year.l-ll. 
Quautitative coronary angiography 
Since visual reading of angiograms underestimates the extent of coronary disease, a 
more objective method for detecting and monitoring cardiac allograft coronary artery 
disease is needed. De Feyter et al29 discussed the value of quantitative coronal}' angiography 
in clinical trials to describe the progression and regression of coronal}' artery disease. The 
parameter most suitable to assess the progression of d(lfllse coronalY artery disease, is the 
mean segment width. Therefore, this measurement was used in this study to describe the 
changes in the coronary arteries of the cardiac transplant recipients. Changes within each 
patient were analyzed, based on a "patient global score" of all analyzable segments of the 
coronary tree. No significant differences of tbis patient global score were apparent in this 
group of transplant recipients (Tables 2). Similar, in a larger series of 119 patients who 
underwent a transplantation at our center, the prevalence of anatomical significant lesions 
(>50% stenosis in the epicardial branches by visual assessment) one year after 
transplantation was very low (I %). In this study the prevalence of minimal wall 
irregularities and other minor abnormalities of the coronary artery tree, was 349'08. 
Compal'ison with other studies using quantitative coronary angiography 
The changes in the first year after transplantation were first described in 199012 in a series 
of 25 patients. The segment global score decreased by 9.2% in both proximal and distal 
segments. The patient global score also showed a significant reduction from 2.44 ± 0.26 mm 
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Table 5. Comparison of quantitative coronary angiography-studies 
Institution Thoraxcenter Rotterdam 
Number of patients 30 
Number of segments 249 
Patient global score (mm) 
baseline 3.39 ± 0.34 
I year 3.35 ± 0.34 
NS 
Segment global score 
baseline 3.40 ± 0.82 
1 year 3.36 ± 0.83 
change (mm) -0.05 ± 0.32 
(%) -1.0 ± 9.2 
Clinical parameters 
Rejection episodes t 1.2 ± 1.0 
Maintenance immunosuppression 
Cyclosporine and 
prednisone (pts) 25 
Cyclosporine, prednisone 
and azathioprine (pts) 5 
* measurements in a subgroup of patients (n=18) 
t during the first postoperative year 
Stanford University 
25 
353 
2.44 ± 0.26 
2.21 ± 0.34 
p<O.OOI 
2.39 ± 0.93* 
2.17 ± 0.86* 
-0.22 
-9.2 
2.9 ± 1.5 
0 
25 
to 2.21 ± 0.34 mIll. In contrast, we observed a reduction of 2.3% only in segment global 
score of vessels with a diameter exceeding 3.77 lllill. No difference was observed in smaller 
vessels (Table 3), while also the patient global score did not change. Furthermore, only 40% 
of the patients in this study showed coronary artery narrowing. compared to 84% in the 
patients in a comparable report12. 
Both studies are very similar with regard to the methods used. The measurements were 
performed using an automated edge detection technique and the cut off levels for significant 
diameter change were 0.11 mm and 0.10 Illl11 respectively. In present ShIdy quantitative 
analysis was limited to larger epicardial segments (baseline segment global score 3.40 ± 
0.82 mm versus 2.39 ± 0.93 mm), and fewer segments per patient were measured (mean 8.3 
versus 20.6, table 5). This selection cannot explain the difference between both studies, 
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since we observed no changes in the smaller vessels. 
Clinical and laboratory data of both studies are also comparable, except the number of 
rejection episodes in the fIrst postoperative year, which was lower at the Thoraxcenter, and 
the immunosuppressive regimen, which seemed less extensive for maintenance therapy 
(Table 5). Neither study, however, could detect a relation between the number of rejection 
episodes or immunosuppressive therapy and the changes in coronary vessel diameter. 
The small changes in lumen diameter in the present study may be a result of specific 
characteristics of the treatment strategy. In contrast to many other centers, 83% of the 
patients in present study received the calcium-channel blocker nifedipine for 8. J ± 3.8 
months. This may have reduced changes in coronary diameter since a recent randomized 
trial reported a simi1ar favourable effect of another calcium-channel blocker: diltiazem13• 
Moreover, the patients in present study received at least one bloodtransfusion prior to 
transplantation". CMV disease was infrequent, probably due to the prophylactic use of 
CMV hyperimmunoglobulin after transplantation in seronegative patients. Only 12 patients 
were infected with CMV of whom 7 patients developed CMV disease35• Still it remains 
speculation whether these factors have contributed to the more favourable coronaty artery 
diameter in our series, since no specific risk factors for accelerated coronmy artery disease 
were identified uptill now. 
Conclusions 
In comparison with other early post transplant studies '2 we observed only minimal 
changes in coronary luminal diameter, expressed in a patient global score and a segmental 
score in the first year after cardiac transplantation. Most of the patients used a calcium-
channel blocker. No relation with potential risk factors, as described in the literature could 
be found. To overcome the differences in definition of accelerated coronary artery disease, 
serial quantitative coronary angiography, should be applied in large series to achieve better 
understanding of the pathophysiology of accelerated coronary artery disease, and to 
investigate the influence of different treatment protocols on tIus process. 
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INTRODUCTION 
Survival after cardiac transplantation has improved over the last years with a I-year 
survival rate of greater than 80% in most transplant centers', At present, one of the most 
limiting factors for medium and long-term survival is the process of graft vasculopathy, an 
accelerated and diffuse form of coronary atherosclerosis2, It accounts for approximately 
60% of all retranspiantation proceduresJ , 
The exact cause of this disease is thought to be immunologic, however direct proof is 
lacking. A major problem comparing the incidences at individual centers are the different 
defInitions and methods to assess this diffuse vasculopathy. Therefore quantitative COrollillY 
angiography is thought to be a more sensitive and objective method for assessment, which 
offers potential for better understanding the pathophysiology and for investigating the 
influence of different treatment strategies on this process. 
In the beginning of this century the first experimental work on cardiac transplantation 
was performed by Carrel and Guthrie. They transplanted the heart of one dog into the neck 
of another dog: the first heterotopic transplantation. The first successful clinical cardiac 
transplantation was performed by Barnard in 1967. Following tIus promising experience a 
large number of transplants were performed throughout the world. However, the immediate 
results after transplantation did not meet the expectations, because of acute allograft 
rejection and infection and consequently only a few centers continued with the development 
of this technique. During the 1970 ts indications and contraindications for cardiac 
transplantation were defined. Treatment of rejection was greatly enhanced by the use of 
rabbit anti-thymocyte-globulin. The detection and surveillance of rejection were facilitated 
by the introduction of trans venous right ventricular biopsy and the development of a grading 
system for the histologic fIndings". 
One year survival increased from 22% in 1968 to 65% in 1978'. The greatest step 
forward however, has been made in the early 1980's by the introduction of cyclosporin A for 
inllllunosuppressions. 
As a result of the use of cyclosporin, cardiac transplantation has been developed to a 
generally accepted treatment for end-stage heart disease. According to the ninth report of the 
Registry of the International Society for Heart and Lung Transplantation, up to december 
1991 over 19,000 heart transplantations have been performed and the one-year survival rate 
has increased to approximately 80%l. 
Accelerated coronary artery disease 
With the improvement of short term survival, it became clear that the process of 
accelerated coronary artery disease is one of the important factors limiting the long term 
survival of cardiac transplant recipients2• Due to the lack of innervation of the cardiac 
allograft, angina pectoris is usually absent, and electrocardiographic signs of myocardial 
infarction, congestive heart failure or sudden death may be the first signs of graft coronary 
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Figure 1. Example of a coronary angiogram in right anterior oblique view of a 60 year old male 
cardiac transplant recipient, 5 year after transplantation, showing the typical diffuse wa11-
irregularities and local stenoses. 
arteriosclerosis9 • 
The histologic findings of graft coronary arteries after human transplantation were fIrst 
described by Bieber et al.lO and confIrmed by othersll-l~. The earliest change consists of 
concentric fibrosis and smooth muscle cell proliferation with collagen accumulation 
creating diffuse intimal thickening. This is seen as early as one week after transplantation. 
Subsequently, these lesions may progress to diffuse obliterative lesions creating longitudinal 
nalTowing and distal pruning. The lesions are generaHy present in the large epicardial 
vessels as well as in the small intramyocardial branches. Therefore, because of the diffuse 
nature of the process, standard revascularization techniques such as bypass grafting and 
percutaneous transluminal coronary angioplasty are of limited value. 
To detect the onset and progression of coronary disease in an early phase, coronary 
angiography is performed annually in most transplant centers. Gao et al. 15 first described the 
specific angiographic morphology of the lesions found after transplantation by dividing 
them into 3 categories: type A, discrete or short tubular stenosis in the proximal, middle or 
distal segments of major coronary arteries or their branches, type B; diffuse concentric 
luminal nalTowing in the middle to distal segment branches; and type C, diffusely narrowed 
irregular distal branches that are squared of and end abmptIy, the latter t\VO groups both 
unique to the post-transplant patients (Figure I). Despite this clear categorization, the 
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reported incidences of visually detectable coronary artery disease vary considerably, ranging 
from 2 to 34 % at 1 year, and ranging from 50 to 73 % at 6 years after transplantationlH3• 
Thus, visual interpretation of coronary angiography has limitations for both clinical and 
research purposes: The results of different transplant centers are not comparable, and the 
influence of different treatment strategies cannot be assessed. 
Quantitative coronary angiography 
Quantitative coronary angiography has the advantage of being more accurate and 
reproducible for the assessment of coronary artery disease. De Fey tel' et a}.2~ discussed the 
value of quantitative coronary angiography in clinical trials concerning progression or 
regression of coronruy artery disease. A specific tool to assess the progression of diffuse 
coronalY artery disease is the mean segment width measured in millimeters. It is also the 
single measurement to detect both diffuse and focal atherosclerosis. Therefore mean 
segment width should be the appropriate measurement to be used in cardiac transplant 
recipients. The description of progression and regression of allograft coronary mtery disease 
should include 2 parameters: Firstly, a description based on the coronmy status of an 
individual patient: the patient global score, ,vhich is defined as the average of the mean 
width of all analyzable segments of the coronat)' tree (including those with lesions) per 
patient. The patient global score change is defined as the average change in the mean width 
of the segments (Table 1). Secondly, a description based on all the segments measured in a 
study: the segment global score, which is defined as the mean of the coronary segment 
widths of all these measured segments. Segment global score change is defined as the 
average change of all segments (Table I). 
O'Neill et al.23 was the first to report a significant reduction of coronalY luminal diameter, 
using quantitative coronary angiography in cardiac transplant recipients. Mean coronary 
diameter of the left main coronary artery decreased from 5.4 ± 0.9 mm at 1 year to 4.7 ± 0.8 
mm at 3 years after transplantation in 20 patients having serial coronru"y angiography. The 
coronary luminal diameters of the proximal and mid left epicardial artelY segments also 
showed a significant decrease. However, distal epicardial segments did not change 
significantly. Quantitative analysis was performed by two observers. In this study vessel 
borders were manually traced in end diastolic frames and measured lIsing digital calipers. 
The patient global score was not presented. Furthermore no relation was found between 
these changes and potential risk factors for development of accelerated coronmy artelY 
disease. 
Stanford University reported the use of quantitative coronal), angiography by automated 
computerized edge detection in a study describing the changes in coronary luminal diameter 
in the fIrst year after transpiantation26• In a group of 25 patients mean coronary diameter 
decreased from 2.44 ± 0.26 mm at an average of 5.1 weeks after transplantation to 2.21 ± 
0.34 nm) at I year follow-up (p < 0.001). Although absolute changes were less in smaller 
arteries, there ,vas no significant difference between large (> 2.9 mm), medium (2.0 - 2.9 
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Table 1. Example of the calculation of patient global score and patient global score 
change in a cardiac transplant recipient. 
SEGMENT NUMBER * BASELlNEt FOLLOW-UP ~ CHANGE + 
(1llll1) ( mm) (mm) 
3.75 3.64 -0. II 
2 3.65 3.28 -0.37 
3 3.29 3.23 -0.06 
5 4.00 3.47 -0.53 
6 4.44 3.99 -0.45 
7 3.19 3.23 0.04 
8 2.40 2.28 -0.12 
II 2.70 2.57 -0.13 
13 2.24 2.13 -0.11 
patient global score 3.30 ± 0.74 3.09 ± 0.63 -0.20 ± 0.20 
* Segment number according to the American Heart Association Classification15 
t Mean segment width at baseline coronary angiography 
=1= Mean segment width at follow-up coronary angiography 
mm) and small « 2.0 mm) vessels with regard to percentage change (-9.4, -10.9 and -6.4%, 
respectively). In tlus ShIrly also 110 relation with potential risk factors for transplant coronary 
artery disease could be found. Mills et a1.27 recently reported COroOillY artcIY segment 
measurements in 18 patients from 1 to 3 years after cardiac transplantation, using cine-
videodensitometry. All angiograms were visually interpreted as "normalu by all experienced 
investigator, using side-by-side projectors. No loss of distal branches was seen. Using 
quantitative analysis all segments except the proximal left anterior descending segment 
showed a significant decrease from the first to the third postoperative year (range -0.19 to 
-0.48 mm). They concluded that graft arteriopathy is ubiquitous in heart transplant 
recipients, however no new insights on the pathogenesis of graft arteriopathy were given. 
THE THORAX CENTER EXPERIENCE 
Visual analysis of the coronary angiograms of all patients who underwent a cardiac 
transplantation between June 1984 and May 1990 at the Thoraxcenter, made as part of their 
annual follow-up protocol, revealed a prevalence of abnormalities of the epicardial vessels 
in this patient group increasing from 34% at one year to 79% after 5 years. A velY low 
threshold for assessment of visual coronary artery disease was used by two observers 
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experienced in the rcading of post transplant coronary angiograms. However, the prevalence 
of anatomical significant lesions (>50% stenosis in the epicardial branches or abrupt 
ending/proximal occlusion of tertimy branches) was only 1% at one year and 11% after 5 
years20• 
In order to provide a more accurate and objective evaluation of the development of 
coronary artery disease, a study was initiated at the Thoraxcenter to describe the changes in 
coronary luminal diameter of the epicm'dial branches using serial quantitative coronary 
angiography. Furthermore, these changes were con-elated with potential risk factors, as 
described in the literature. 
PATIENTS 
All cardiac transplant recipients who underwent a coronary angiography, as part of their 
annual follow-up protocol, between September 1989 and September 1990 were included in 
this study. Five subgroups could be identified: The fIrst group consisted of 30 patients 
undergoing early angiography within one month after transplantation. The second, third, 
fourth and fIfth groups consisted of28, 21, 23 and 9 patients having angiography 1,2,3, and 
4 years after cardiac transplantation respectively (Tables 2 and 3). In the subsequent year all 
patients underwent follow-up coronary angiography, thus achieving serial aIle year follow-
up coronroy angiography. 
Six patients were excluded from this study: I patient died before follow-up angiography, 
in 2 patients follow-up angiography was not performed because of severe kidney failure, 
and in 3 patients follow-up angiography was postponed because of either infective disease 
or rejection. 
Eady prophylactic immunosuppressive therapy consisted of either polyclonal anti-T cell 
antibodies (Horse anti-thymocyte globulin, anti-thymocyte IgG2, Lymphoglobulin, Institute 
Merieux) or monoclonal anti-T cell therapy (OKT3, Ortho Pharmaceutical, Raritan, N.J.)l3. 
Maintenance immunosuppression consisted of low dose steroids and cyc1osporin. 
Azathioprine was added to tillS regimen in 16 patients because of reCUlTellt rejection, 
detected and monitored by endomyocardial biopsies. The histologic findings of these 
biopsies were graded according to Bi1linghams criteria5 until December 1990, and by the 
guidelines of the International Society for Heart and Lung Transplantation6 from Janumy 
1991. In cases of moderate rejection with defiIllte myocyte necrosis (Billingham grade 2) or 
grade 3A according to latter criteria, additional treatment was instituted, consisting of pulsed 
high dose steroids and poly- or monoclonal anti-T cell therapy. 
In Cytomegalo virus (CMV) seronegative recipients, anti-CMV hyperimmunoglobulin 
(Cytotect, Phanna GmbH, Dreiech, Germany) was administered during the t1rst 10 weeks 
after transplantation29• CMV infection was defined as any rise in serum IgM, isolation of 
crvrv from urine throat or blood, or evidence of CNIV immediate early antigen. CMV 
disease was defined as infection accompanied with fever >38"C for at least 2 days, and either 
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Table 2. Clinical data 
group O-Iyr group 1-2yr group 2-3yr group 3-4yr group 4-5yr 
Number of patients 30 28 21 23 9 
Number of segments 249 227 173 186 75 
Immunosuppressive regimen * 
- Cyclosporine and 25 25 17 20 8 
prednisone (pts) 
- Triple therapy (pts) 5 3 4 3 
Recipient age (yr) t 4H 12 4H II 41±7 44± 10 36± 13 
Donor age (yr) 26±8 25 ± 8 23±7 24 ±8 21 ± 8 
Gender (F/M) 2/28 4/24 2119 2/21 1/8 
Gender mismatch (pts) 9 9 7 10 5 
HLA-mismatch 
A 1.41 0.6 1.3± 0.7 1.3 ± 0.6 1.3 ± 0.6 1.2 ± 0.7 
B 1.6 ± 0.5 1.6 ±0.6 I.HO.5 I.HO.7 1.7±0.5 
DR I.HO.7 1.4 ± 0.7 1.5 ± 0.6 1.2±0.5 1.3± 0.9 
Rejection episodes between 
angiography median (range) I (0-5) 0(0-1) 0(0-1) 0(0-1) 0(0·1) 
Cholesterol (mmolll) + 7.4 ± 1.7 7.0 ±I.6 7.9 ±I.5 7.3 ±I.5 7.6 ± 1.2 
Triglyceride (mmolll) + 2J ±0.8 2.2±0.8 2.4 ±0.9 2.4 ± 1.3 2.5 ±I.0 
HDL-cholesterol (nIDIOIII) + I.HO.5 1.3±0.4 I.HO.5 1.3 ± 0.4 I.HOJ 
Donor heart ischemia (min) 154131 169 ±38 151 ± 38 159 ±45 190±44 
Smoking (YeslNo) * 7/23 6/22 1/20 5118 2/6 
Diabetes (pts) , 2 I I 2 
CMY infection (pts) * 12 3 3 3 I 
CMV disease (pts) , 7 0 0 0 0 
Use of nifedipille (pts) § 20 18 14 16 5 
F = female; M=male; CMV=cytomegalo virus; HDL=High Density Lipoprotein; 
"" = during the follow-up period; t = at the time of the transplantation; 
{: = mean during the follow-up period; § = at follow-up catheterization; 
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leukocytopenia « 2.5 x 10'/1) and thrombocytopenia « 1 00 x 10'/1), or symptoms of organ 
involvemenf9, 
In patients, who never received a blood transfusion before transplantation, a transfusion 
was administered pre~operatively30. All patients were treated with antiplatelet agents, 
consisting of either dipyridamole 75 mg tid or aspirin 80 mg daily. Hypertension was 
preferably treated with nifedipine. 
Quantitative coronary angiography 
All patients undenvellt left heart catheterization and selective COrollillY angiography by 
the femoral approach. Right heart catheterization with pressure measurements was 
performed and five endocardial biopsies were obtained, using the percutaneous transjugular 
approach. 
To reduce the influence of dynamic vessel tone, isosorbide-dinitrate (5 mg) was given 
sublinguaUy before contrast injection. At baseline coronary angiography, standard 
projections were used and replicated at follow-up. 
Off-line quantitative analysis was performed using the computer-assisted Cardiovascular 
Angiography Analysis System (CAAS), which has been described in detail previously"'''. 
Nine epicardial coronmy segments, identified by anatomic landmarks25, were selected 
and analyzed in two orthogonal views avoiding foreshortening. Of the right coronary artery 
the proximal, mid and distal segment were analyzed; of the left coronaty artery the main 
branch and segments 6, 7, 8, II and 13 were chosen for analysis. 
The results were expressed in a patient global score and a segment score as described 
before. 
Statistical analysis 
All data are presented as the mean ± SD. Statistical analysis was performed using the 
\Vilcoxon Matched-pairs Signed-ranks test. Unpaired t tests, one-way analysis of variance 
and logistic regression were used to compare differences in potential risk factors for 
accelerated coronary artery disease. Statistical significance was defined as a p value of 0.05 
or less. 
RESULTS 
Clinical data 
The clinical data of the cardiac transplant recipients in the different subgroups are 
described in Table 2. The number of rejections and Cytomegalo-virus infections was, as 
expected, higher in the first year aftcr transplantation in comparison with the other periods. 
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Table 3. Patient global score 
number patient global score (llllll) patient global score change 
of patients baseline follow-up mm % 
group 0-lyr 30 3.39 ± 0.34 3.35 ± 0.34 -0.05 -1.5 NS 
group 1-2yr 28 3.18 ± 0.37 3.19 ± 0.39 0.01 0.3 NS 
group 2-3yr 21 3.34 ± 0.40 3.26 ± 0.38 -0.08 -2.3 NS 
group 3-4yr 23 3.17 ± 0.27 3.16±0.41 -0.01 -0.3 NS 
group 4-5yr 9 3.23 ± 0.51 3.23 ± 0.46 0.00 0.0 NS 
Table 4. Segment global score 
number segment global score(mm) segment global score change 
of segments baseline follow-up Jilin 
group 0-lyr 249 3.40 ± 0.82 3.36 ± 0.83 -0.05 p=0.007 
group 1-2yr 227 3.17 ± 0.85 3.17 ± 0.82 0.00 NS 
group 2-3yr 173 3.35 ± 0.87 3.28 ±0.81 -0.07 p=0.005 
group 3-4yr 186 3.18 ± 0.78 3.19 ± 0.83 0.00 NS 
group 4-5yr 75 3.23 ± 0.90 3.24 ± 0.86 0.00 NS 
There was no significant difference between groups for mean recipicnt- and dOllor age. 
gender mismatch, HLA-A+B or -DR mismatch, total serum cholesterol, triglyceride. high-
density lipoprotein cholesterol levels, and the other described risk factors for graft 
atherosclerosis. The only risk factor we could identify was the presence of coronary artery 
disease prior to transplantation. In the first subgroup of patients, a significantly larger patient 
global score change was fOllnd in patients with this disease (N= 14), than in patients with 
other indications for transplantation (-0.13 ± 0.17 mm versus 0.03 ± 0.20 mm, p<0.05). The 
changes in minimal luminal diameter were -0.15 ± 0.16 mm and 0.04 ± 0.23 mm (p=O.OI), 
respectively. 
Quantitative angiography 
In the 5 different subgroups of patients 249, 227, 173, 186 and 75 segments were 
analyzed respectively. Only one patient in the last subgroup showed a significant narrowing 
(> 50%) of the left anterior descending artery. 
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Patient global score 
The results are outlined in Table 3. The largest decrease in patient global score occurred 
in the fIrst and third postoperative year. These changes didn't prove to be significant. 
Segment global score 
In Table 4 the results of segment global score calculations are described. It can be 
appreciated that, according to these calculations, the largest changes also occurred in the 
first and third year after transplantation. This decrease was 0.05 and 0.07 mill respectively, 
and proved to be statistically significant. 
DISCUSSION 
In view of the described studies, the changes in tlus group of patients were small, both 
for patient global score and segment global score, ranging from -0.08 to 0.01 mm in the 
different yearly postoperative periods. 
The exact cause of accelerated coronary artery disease is not yet elucidated. However, it 
is widely believed that immune mediated phenomena play an important role in the 
pathogenesis of this disease, because of it's diffuse nature, involving the entire length of the 
coronary artery tree with sparing of the native vessels, and it's development in patients of all 
ages. The "response to injmy mechanism", due to damage to the endothelium during graft 
rejection, is widely believed to be the most basic etiologic factor, although both in this study 
as in others this hypothesis could not be confirmed19.2(U~.H.J-f. A number of potential additional 
risk factors such as the presence of Cytomegal0 virus infectionJ5.)7, the presence of B-cell 
antibodies3s 01' anti-HLA antibodies)9, the immunosuppressive regimen40, plasma 
triglycerides~l, diabetes mellihls41, donor age37,39.~1 could also not be confirmed by other 
studies. Please note that most of these studies are based on visual, and thus subjective, 
interpretation of coronary angiography. Our shldy shows that quantitative coronary 
angiography offers potential for a better and more objective description of the changes in 
the coronary artery tree and for investigating the factors that influence the development of 
the disease. 
One of the first studies comparing the effect of different treatment strategies using an 
objective edge detection system was described recently in a report of Stanford43• In a placebo 
controlled study in 106 patients, the beneficial effect of the calcium-antagonist diltiazem to 
inhibit early post-transplant coronary luminal nal1'owing was described. In the 54 patients, 
who received placcbo, segment global score decreased significantly from 2.41 ± 0.27 mm 
at baseline (median, 19 days aftcr transplantation) to 2.22 ± 0.26 mm at 2 year follow-up. In 
the same period, segment global score of the patients who received the calcium-antagonist, 
changed from 2.32 ± 0.22 nun to 2.36 ± 0.22 mm, a not statistically significant change. In 
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our study most transplant recipients also received a calcium-antagonist (nifedipine), but no 
relation was found between the use of nifedipine and the development of post transplant 
coronary artelY disease. 
An increase in coronary artery dimension was first reported by Von Scheidt et al..t-t in 5 
out of a group of 68 patients after transplantation (7.3%). No causal relation with clinical 
data could be determined. However, tlus process was assessed by visual interpretation of 
coronary angiography and has not been confirmed by quantitative methods. 
CONCLUSION 
The coronary luminal diameter, expressed in a patient global score and a segmental 
score, decreased in the first and third year after cardiac transplantation. However, we 
observed only minimal changes in comparison with other post transplant studiesB ,16,27. 
Furthermore, these changes seemed to be clinically insignificant. Pre-transplant coronary 
artelY disease of the recipient was identified as a risk factor for the development of 
transplant coronary atherosclerosis in the first postoperative year. No relation was found 
with other described potential risk factors. 
To overcome the differences in defiIution of accelerated coronary artelY disease, serial 
quantitative coronary angiography, if used in larger studies, can be an objective method to 
assess the incidence of this disease. Therefore, it offers potential for better understanding the 
pathophysiology of accelerated coronary artelY disease, and for investigating the influence 
of different treatment protocols on this process, 
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ABSTRACT 
Reported incidences and risk factors of accelerated diffuse coronary disease after cardiac 
transplantation (HTX) vmy considerably. To further elucidate the development of transplant 
coronary artery disease and the risk factors for such development, a 2 year follow-up study 
was pClformed in 104 patients, starting between 1 month and 4 years after transplantation. 
Initial quantitative coronary angiography was performed in 30, 26, 20, 20 and 8 patients, 
respectively at 1 month and 1, 2, 3 and 4 years after the operation, and replicated in each 
patient 1 and 2 years later. Maintenance immunosuppression consisted of low dose steroids 
and cyclosporine in 90 patients; in 14 patients azathioprine was added. Hypertension was 
preferably treated with nifedipine. Cytomegalo vims (CMV) seronegative patients received 
anti-CMV hyperinul1unoglobulin after transplantation. 
Changes in the epicardial coronary arteries were evaluated by quantitative angiography 
using an automated edge detection system at different intervals after transplantation. The 
average change in mean lumen diameter in the fIrst year after transplantation was -0.05 mm. 
In the following years the changes were -0.01, -0.03, +0.01, +0.05 and +0.12 mm 
respectively. None of these changes proved to be statistically significant on a patient based 
score. On a per patient basis, 33 patients showed progression of focal atherosclerosis, 39 
patients showed regression and 32 had either a mixed response or no change during 2 year 
follow-up. Although the development of coronmy disease is thought to be of immunologic 
origin, no relation with rejection episodes could be established. No other risk factors for 
development of coronary disease could be identified. 
Conclusion: Serial quantitative coronary angiography demonstrated no significant 
reduction in mean diameter of epicardial coronary arteries during 6 years follow-up after 
heart transplantation, and no risk factors for changes in individual patients could be 
identified. Larger studies with longer follow-up are wan-anted in patients receiving different 
medical regimens after transplantation. 
INTRODUCTION 
Long term survival of cardiac transplant recipients is limited by the development of 
accelerated coronary artery disease. TillS diffuse and progressive type of coronary artery 
disease accounts for the majority of deaths after cardiac transplantation, and for 60% of the 
retransplantation procedures l -3• The exact cause of this disease has not yet been elucidated. 
Damage to the endotheHum during graft rejection, is thought to be an etiologic factor 
(response to injury mechanism), although most studies could not confirm a relation between 
recoglllzed rejection episodes and the development of transplant coronary artery disease~-7. 
Conflicting data have been presented concerning the association of additional risk factors 
and the presence of accelerated coronary artery disease. Incriminated factors include 
Cytomegal0 virus infectionsS-IO , the presence of B-cell antibodies ll or anti-HLA antibodies ll , 
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the employed immunosuppressive regimen4,8,\3,!4, elevated plasma triglycerides\3,!6, diabetes 
mellitus lO and higher donor age8•lO,16. 
Most studies were based on visual interpretation of the coronary angiograms. The 
assessment of the disease was thus subjective and not comparable between centers. 
Quantitative coronary angiography offers a more objective method to monitor luminal 
changes, and has been applied in a few studies in small patient groups, during a limited 
follow-up periodl 6-19. Therefore, we performed quantitative analysis of serial coronary 
angiograms in a larger series of patients, to describe the changes in coronary luminal 
diameter at different postoperative stages up to 5 years after transplantation and to correlate 
these changes with previously identified risk factors. Data from patients at different 
intervals after transplantation were combined to obtain a complete pattern of angiographic 
changes during the first 6 years after transplantation. 
PATIENTS AND METHODS 
Patients 
From October 1989 until October 1990 113 consecutive cardiac transplant recipients 
underwent coronary angiography at different postoperative intervals, as part of an annual 
follow-up protocopo. All patients had undergone orthotopic heart transplantation at the 
Thoraxcenter of the University Hospital Rotterdam, Dijkzigt. Five subgroups were 
identified as described in table I. Thirty patients (group A) underwent coronary angiography 
within one month after transplantation. In the other groups the baseline coronary angiogram 
for this study was made at I, 2, 3 and 4 years after transplantation respectively. All patients 
were asked to return for coronary angiography in the subsequent two years, thus achieving 
serial one and two year follow-up coronary angiography. These data were complete in 104 
Table 1. Distribution of the patients in the different groups, according to the time of 
the angiography. 
Serial quantitative angiography 
Lost to 2 year 
Group I month· I year I ·2 years 2·3 years 3·4 years 4·5 years 5·6 years [ollow·up 
A 30 30 
B 30 26 4 
C 21 20 
D 23 20 3 
E 9 8 
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patients. Each patient served as its own control for the measurement of changes in coronary 
diameter. Thus five patient cohorts were studied with observations at different intervals after 
transplantation: 0-2, 1-3, 2-4, 3-5 and 4-6 years respectively (Table I). 
Immunosuppression and other prophylactic pre~ and peri-operative measures 
Induction immunosuppressive therapy consisted of either polyclonal anti-T cell 
antibodies (Horse anti-thymocyte globulin, Lymphoglobulin, Institute Merieux, Lyon, 
France) or monoclonal anti-T cell therapy (OKT3, Ortho Pharmaceutical, Raritan N.J., 
U.S.A.rl. Maintenance immunosuppression consisted of low dose steroids and 
cyclosporine. Azathioprine was added to this regimen in 14 patients with frequent rejection 
episodes. Endomyocardial biopsies were used to detect and monitor acute rejection. The 
histologic fIndings were graded according to Bil1inghams criteria22 until December 1990, 
and by the guidelines of the International Society for Heart and Lung TransplantationD from 
January 1991. In cases of moderate rejection with definite myocyte necrosis22 or grade 3A23 
additional treatment was instituted, consisting of pulsed high dose steroids or poly- or 
monoclonal anti-T cell therapy. 
Cytomegalo virus (CMV) seronegative recipients received anti-CMV immulloglobulin 
(Cytotect, Biotest Pharma GmbH, Frankfurt, Germany) during the first 10 weeks after 
transplantation2-1. CMV infection was defined as any rise in serum immunoglobulin M, 
isolation of CMV from urine throat or blood, or evidence of CMV immediate early antigen. 
CMV disease was defined as infection accompanied with fever of more than 38°C for at least 
2 days, and either leukocytopenia (less than 2.5 x 10'/1), thrombocytopenia (less than 100 x 
109/1), or symptoms of organ involvement25 • 
In patients who never had received a blood transfusion before transplantation, a 
transfusion was administered during the screening period. Anti-leukocyte-antibodies were 
measured preoperatively to determine the necessity of preoperative cross matching with 
donor blood, which was performed if the percentage of antibodies, measured with a standard 
leucocyte panel, exceeded 5%26. 
All patients received antiplatelet therapy, consisting of either dipyridamole 75 mg three 
times daily or aspirin 80 mg/day. Hypertension was preferably treated with the calcium-
channel blocker nifedipine in a slow release preparation. 
Quantitative coronary angiography 
All patients underwent left heart catheterization and selective coronary angiography by 
the femoral approach at three consecutive years. The projections used at baseline coronary 
angiography were documented and replicated at follow-up. To reduce the influence of 
dynamic vessel tone, isosorbide dinitrate (5 mg) was given sublingually before the first 
coronary contrast injection. 
Off-line quantitative analysis was performed using the computer-assisted Cardiovascular 
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Angiography Analysis System (CAAS)lw. After correction for pincushion distortion caused 
by the image intensifier, the mean and minimal coronary width of each segment were 
calculated in millimeters. The catheter tip or shaft, filmed without contrast, was used for 
calibration. 
Nine epicardial coronary segments, identified by anatomic landmarks, as defined by the 
American Heart Association29, were selected: the proximal, mid and distal segments of the 
right coronary artelY, the main branch and the proximal, mid and distal segments of the 
anterior descending branch as well as the proximal and mid segment of the circumflex 
branch of the left coronalY artelY. All segments were analyzed in two views, preferably 
orthogonal or separated by at least 30°, avoiding foreshortening. 
1\vo parameters were used in this study to describe the progression or regression of 
coronary artery disease3o• The patient global score provided a description of diffuse coronary 
artery disease, and was defined as the per-patient average of the mean widths of the 9 
measured segments. The threshold used to assess significant change in patient global score 
was 0.20 mm, which is two times the standard deviation of the measurement of mean width 
in non~obstructed segments27. In addition, the minimal luminal diameter per segment (MLD) 
was used to assess development of focal disease. A change of 0.40 mm was considered to 
be clinically significant)!. Table 2 summarizes the definitions of progression or regression of 
focal coronmy artery diseaseH • 
Statistical methods 
All data are presented as the mean ± SD. Statistical analysis of the changes in patient 
global score was performed using the Wilcoxon matched~pairs signed~rank test. One-way 
analysis of variance (ANOYA) and linem' regression analysis were used to assess the 
association of potential risk factors with accelerated coronmy artelY disease. A chi square 
test was performed to calculate the risk for development of transplant coronay artery disease 
for each potential risk factor. Continuous variables were dichotomized by cutpoints on the 
Table 2. Definition of changes in focal coronary artelY disease 
Progression: At least one segment progressed and none regressed 
Mixed: One segment regressed and at least one progressed 
Stable: No segments progressed or regressed 
Regression: At least aile segment regressed and none progressed 
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basis of the median value. Multivariate analysis was performed using logistic regression to 
identify variables independently correlated with the occurrence of accelerated coronary 
artery disease. All statistical analyses were carried out with a commercial statistical package 
(BMDP statistical Software Package). P values (two tailed) were considered significant only 
when less than 0.05. 
RESULTS 
Clinical data 
Complete data at baseline, one and two year follow-up, were obtained in 104 patients 
(Table I). Nine patients were lost to 2 year follow-up: one patient died; in 2 patients the final 
angiogram was not made because of severe renal failure; one patient had a cerebra vascular 
accident during the second angiogram and therefore the third follow-up angiogram was 
cancelled, and in 5 patients the final angiogram was cancelled because of other medical and 
organisational reasons. 
The baseline characteristics of the eligible patients in the different subgroups are shown 
in table 3. Of these 104 patients, 95 were male and 9 female. Recipient ages ranged from 13 
to 61 years (mean 44 ± 7 year). As expected, the numbers of rejection episodes and 
cytomegalo-virus infections were higher in the first year after transplantation than in the 
other periods. There was no difference between the groups with respect to mean values of 
recipient- and donor age, gender mismatch, HLA-A+B or HLA-DR mismatch, total serum 
cholesterol, triglyceride, high-density lipoprotein cholesterol levels and the other described 
risk factors for graft atherosclerosis. 
Angiography 
At baseline angiography, no significant nanowing (more than 50% by visual assessment) 
was observed. By visual assessment 27% of the patients showed evidence of diffuse 
coronary artery disease in the large epicardial vessels. The smaller branches were affected 
in 54% of these patients. At I year follow-up, the angiogram of 1 patient in subgroup E 
showed a significant narrowing of the left anterior descending artery, which was treated by 
balloon angioplasty. At 2 year follow-up, 4 patients had developed a ~ 50% stenosis in one 
segment of the coronary tree. 
Quantitative coronary angiography 
In the 5 different subgroups of patients 827 segments were analyzed. The lllean segment 
diameter was 3.26 ± 0.82 mm at baseline angiography. In table 4 the changes in patient 
global score in the different postoperative stages are shown. These changes were small, and 
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Table 3. Baseline characteristics 
group A group B group C group D group E 
Angiographic follow-up * 0-2 1-3 2-4 3-5 4-6 
Number of patients 30 26 20 20 8 
Recipient age (yr) t 45 ± 12 451 II 47±7 44± 10 36 ± 13 
Donor age (yr) 26± 8 518 23±7 24 ± 8 21 ±8 
Gender (F/M) 2/28 3/23 lII9 2/18 117 
Gender mismatch (pts) 9 7 6 9 4 
HLA-mismatch 
A 1.4 ± 0.6 1.3 ± 0.7 1.3± 0.6 1.3 ± 0.6 1.2 ± 0.7 
B 1.6 ± 0.5 1.6 ± 0.6 1.51 0.5 1.5 ± 0.7 1.7 ± 0.5 
DR 1.5 ± 0.7 1.4 ± 0.7 1.5 ±0.6 1.2± 0.5 1.3 ± 0.9 
Immunosuppressive regimen t 
- Cyclosporine and prednisone (pis) 25 24 16 18 7 
- Triple therapy (pts) 5 2 4 2 I 
Donor heart ischemia (min) 154 ± 31 168 ± 37 151 ± 38 159 ± 44 183± 42 
Indicalion for HTX 
(ischemiclother) 14116 12114 1119 1119 315 
Rejection episodes between 
initial and 1 year I (0-5) 0(0-1) o (O·l) 0(0-1) 0(0-1) 
1 and 2 year, median (range) 0(0·1) 0(0-1) 0(0-1) 0(0-1) 0(0-0) 
Smoking j: (Yes I No) 7123 6120 1119 5/15 216 
CMV serology (poslneg) 17113 17/13 11110 121ll 316 
CMV infeclion (pis):} 12 3 3 3 I 
CMV disease (piS) t 7 0 0 0 0 
Choleslerol (nnHolll) $ 7.4 ± 1.7 7.0 ± 1.6 8.0 ± 1.5 7.3± 1.5 7.6 ± 1.2 
Triglyceride (nllnolll) $ 2.3±0.8 2.3±0.8 2.4 ± 0.9 2.4 ± 1.3 2.5 ± 1.0 
HDL-choleslerol (mmolll) S 1.5 ± 0.5 1.4 ± 0.4 1.5 ± 0.5 1.3 ± 0.4 1.5 ± 0.3 
Diabetes (pts) j: 2 I I 2 
Use of calcium anlagonisl (pis) 26 22 15 16 6 
F::::female; M=male; CMV=Cytomcgalo vims; HDL::::High Density Lipoproteins; »:;:;study period 
related to the post-transplant survival; 
t=at transplantation; +=dUrillg the study period; S=mean dming the follow-up period 
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Table 4. Changes in patient global score in the different post-transplant intervals (mm) 
Follow-up period 
Group n I month· I year 1 ·2 years 2· 3 years 3·4 years 4 - 5 years 5 -6 years 
A 30 ·0.05±0.20 ·0.03±0.21 
B 26 0.01 ± 0.15 0.00±0.14 
C 20 ·0.08 ±O.l8 0.02±O.l6 
D 20 ·0.01± 0.21 0.08±O.l4 
E 8 0.00 ± 0.20 0.1210.27 
Patient 
global score ·0.05 ± 0.20 ·0.01 ±O.l8 ·0.03±O.l6 0.01 ±O.l9 0.05±O.l6 0.12 ±0.27 
l1-ntunber of patients in each group with three complete angiograms (see table I), 
statistically not significant. There was a trend towards nanowing of lllean segment diameter 
in the fust 3 years, and widening in subsequent years (Figure 0, However, these changes 
were not statistically significant. 
Changes in patient global score in 50 patients with and 54 without visually detected 
progression of transplant coronary artery disease, according to the criteria as described by 
the group of Stanford" were equally distributed (Figure 2). 
Progression of focal coronary artery disease was found in 33 patients. Both progression 
in some and regression in other segments was observed in 19 patients, while no such 
changes were apparent in 13 patients. Thirty-nine patients showed regression of focal 
coronary artelY disease. 
Risk factors 
By univariate analysis, the incidence of diffuse transplant coronary artery disease 
appeared lower in patients who continued smoking after transplantation (p=O.02) (Table 5). 
After correction for co-variates using multiple logistic regression analysis, not-smoking was 
retained in the model as an independent predictor of the occurence of diffuse accelerated 
coronary artery disease. 
The described risk factors for diffuse coronary artery disease were also included in a 
logistic regressiolllllodel to assess the likelihood of the occurrence of/ocal coronary artery 
disease. Both not-sllloking and the occurence of rejection between the baseline and two year 
follow-up angiogram \"ere retained in the model as an independent predictor of the 
occurrence of focal coronary artery disease (Odds ratio smoking 0.33; 95% CI 0.08-1.15 aud 
rejection 3.0; 95% CI 1.10-8.19, respectively). 
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Figure 1. Changes in patient global score at different post-transplant intervals. Changes within each 
year have been added to changes in previous years to demonstrate the 6 year trend in patient global 
scores. Mean change and standard deviation are shown. The threshold lIsed to assess signiticant 
change in patient global score (0.20 mill) is drawn in the tigure. 
DISCUSSION 
In contrast with earlier reports l6-1S, serial quantitative coronary angiography revealed no 
significant reduction of mean diameter of epicardial coronary arteries up to 6 years after 
transplantation. Nevertheless, progression of focal coronary artery disease occurred in 32% 
of the patients. The role of previously identified risk factors for the development of transplant 
coronary artery disease could not be confirmed. 
In this study the severity of accelerated diffuse coronary artery disease was less extensive 
in comparison with other shldies. In particular, other groups reported larger changes in 
coronary luminal diameter, both in the first year after transplantation (9.2% decrease of mean 
coronary diameter, corresponding to 0.22 llun)l6, and between the first and third year after 
transplantation (7% decrease of mean coronary diameter = 0.20 1111n)17. Yet, our findings were 
in agreement with an earlier report from the Thoraxcenter10 in which the incidence of 
abnormalities in primary and secondary epicardial branches, by visual interpretation of the 
coronary angiograms, increased from IS to 57% in the first 5 postoperative years in 119 
patients who received similar treatment as in the present study. TIllS may have contributed to 
the excellent five year patient survival rate of 84% (CI 78-90%) at our center. 
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Table 5. Progression of coronary artery disease and risk factors * 
Risk 1~1ctor Patient positive for the 
risk factor: CAD / total 
Age recipient 
(> 50.2 years) 10/52 
Age donor (> 23 years) 12/52 
Males 20/95 
Gender mismatch 8/35 
Number of HLA 
mismatches (> 4) 6/45 
Ischemia of the 
donorheart (> 160 min) 7/44 
Indication for HTX: IHD 8/51 
Number of rejection 
episodes (> 0) t 7/28 
Number of early rejection 
episodes (> 0) + 26/90 
Smokiog 1/25 
CMV illfectioos 5/27 
CMV disease 1/7 
Semm Cholesterol 
(> 7.55 mmolll) 10/52 
Semm triglyceride 
(> 2.26 nUllolII) 9/50 
Sennn HDL·Cholesterol 
(> 1.29 nllllolll) 13 / 52 
Use of Nifedipine 
« 22.8 months) 10/52 
Patient negative for the 
risk factor: CAD / total 
III 52 
9/52 
1I9 
13/69 
15/59 
14/60 
13 /53 
14/76 
5/24 
20/79 
16/77 
20/97 
III 52 
12/54 
8/52 
III 52 
Odds ratio 
(95% Cl) 
0.89 (0.31 to 2.36) 
1.43 (0.49 to 4.19) 
2.13 (0.24 to 48.12) 
1.28 (0.42 to 3.82) 
0.45 (0.14 to 1.41) 
0.62 (0.20 to 1.87) 
0.57 (0.19 to 1.68) 
1.48 (0.46 to 4.62) 
1.83 (0.56 to 6.33) 
0.12 (0.0 I to 0.95) 
0.87 (0.24 to 2.94) 
0.64 (0.03 to 5.99) 
0.89 (0.31 to 2.36) 
0.77 (0.26 to 2.22) 
1.83 (0.62 to 5.47) 
0.89 (0.31 to 2.36) 
Hypertension 9/41 12/63 1.22 (0.42 to 3.55) 
* all 104 patients with 2 year follow-up; t=during the study period; +=in the first postoperative year; 
fHD=lschemic Heart Disease; CMV=Cytomegalo vims; CAD=Patients with diftilse transplant 
coronary artery disease. assessed by quantitative coronary angiography (threshold of 0.20 mm) 
The small changes in patient global score in tIus shlrly lllay be a result of specific 
characteristics of the postoperative treatment strategy. Most patients received the caiciulll-
channel blocker nifedipine. Other groups already reported the beneficial effect of the use of 
other calcium-channel blockers in patients with coronary artery disease3J, especially in 
cardiac transplant recipicntsl9• 
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Figure 2. Cumulative curves of changes in patient global score in 50 patients with and 54 without 
visually assessed progression of diffuse coronary artery disease in epicardial coronary arteries 
(CAD). 
Accelerated coronal), artel), disease involves the entire length of the coronary artery trec. 
Histologic findings include concentric fibrosis and smooth muscle cell proliferation with 
col1agen accumulation creating diffuse intimal thickening. Subsequently, these lesions may 
progress to diffuse obliterative lesions and distal pruning3-l·36. The selective involvement of 
the coronary tree of the graft, its diffuse nature and its development in patients of all ages! 
suggest that immune-mediated phenomena may play an important role in the pathogenesis 
of accelerated coronary artet)' disease. Therefore, the number of HLA-mismatches and the 
number of rejections are thought to be risk factors for the development of coronary artery 
diseaseH }7-}9. TIlls study was underpowered to confirm this relation. Using the odds ratio's 
of table 5, sample size calculations show that a larger study in more than 560 patients will 
be necessary to demonstrate a relation between the number of rejection episodes and the 
occurrence of diffuse coronary artery disease. 
The presence of Cytomegalo virus (CtvlV) infection as a risk factor was described by 
Cameron et aIs, and an association behveen viral infections and atherosclerosis was shown in 
animal expel'iments'o. In the present study such association was not confirmed (Odds ratio 
0.99; 95% CI 0.34 to 2.83). Again, the sample size may have been inadequate to detect such 
variation. It is however, also possible that the profylactic treatment of CMV negative patients 
with anti-CMV immunoglobulin may have prevented accelerated transplant coronary artery 
disease in part of our patients. Also the effect of known risk factors for Hon-transplant 
coronary artery disease as serum lipid levels and diabetes mellitus ~I could not be confIrmed. 
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Surprisingly, the smoking habits of the patients appeared to influence the occurrencc of 
both focal and diffuse coronary artery disease. This unexpected observation can not be 
easily explained and may be a chance finding. 
Limitations 
Quantitative analysis of coronary angiograms was applied to provide an objective 
description of the specific changes in cardiac transplant recipients. This method has been 
used in various progression and regression studies33A2, however the number of publications 
applying this method in cardiac transplant recipients is limited. 
It should be appreciated that the patient global score is an average of 9 measurements. 
Therefore, within one patient an increase in mean width in one segment can compensate a 
decrease in another segment resulting in small changes in patient global score. Furthermore, 
it is possible that the assessment of luminal narrowing by quantitative measurement does not 
reflect the extent of the intimal hyperplasia35)6 whenever intimal thickening is balanced by 
compensatOlY enlargement or aneurysmal medial diJatationH . .w. This is illustrated by the 
marked changes in measurements of focal disease in the present series, with little change in 
patient global scores, 
Intravascular ultrasonography is a more suitable technique to assess the changes in the 
vessel wall in proximal segments, and can thus be a useful addition to the angiographic 
measuremcnts. The appHcation of this technique in cardiac transplant recipients has been 
described in a few recent studies-l5 .. H • Several studies have shown the prognostic importance 
of intimal thickening, measured by intravascular ultrasound, with regard to the risk for 
development of accelerated coronary artery discase45A5• Yet, these studies also show 
conflicting data about the association of risk factors and the presence of transplant coronary 
artery disease. Therefore further studies in larger patient groups remain necessmy. 
Conclusions 
In this group of patients, the changes in coronary luminal diameter in the first 5 years 
after cardiac transplantation were small in comparison with other studies applying 
quantitative coronary angiography. The patient global score did not change significantly at 
different postoperative intervals. No relation with described risk factors could be found, 
although smoking seemed to have a beneficial effect. Therefore, no specific 
recommendations can be made concerning the prevention of accelerated coronary artery 
disease and further evaluation in a larger patient groups remains necessary to verify these 
findings. 
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INTRODUCTION 
Since its introduction, coronary arteriography has been of great importance for the 
diagnosis and management of patients with ischemic heart disease', Although location and 
morphology of coronary artery stenoses can sufficiently be assessed by this technique, 
information about their functional significance cannot always be obtained from the 
arteriogram alone2--1, 
The concept of coronary flow reserve (CPR) has been developed to describe the 
relationship between the angiographic severity of coronary artelY disease and the resulting 
reduction or limitation of maximal coronary blood flow in the myocardium3-7. Even in the 
absence of focal atherosclerosis or other flow limiting factors in major epicardial vessels, 
CPR measurements can be used to evaluate dysfullction of the microcirculation. This is 
especially relevant in cardiac transplant recipients, where a diffuse arteriopathy can reach a 
flow Jimiting significance, without changes in the angiographic appearance8,9. 
Different techniques of coronary flow reserve measurement have been described, and 
used in clinical practice. In general, these techniques are designed for application during the 
catheterization procedure, like venous blood flow measurements in the coronary sinus, or 
the assessment of phasic coronmy blood flow velocities using ultrasonic Doppler catheters. 
The latter technique requires the insertion of hardware in the coronary artelY tree, and is 
extremely "space dependentlilO. Finally, the radiographic assessment of myocardial 
perfusion, using contrast media, combines the videodensitometric approach with digital 
subtraction angiography. Compared with the other invasive techniques to measure CFR, Hus 
approach has several advantages. First of ali, the digital subtraction technique is more easily 
applicable during routine catheterization, because no additional catheter or intracoronary 
device has to be used, which makes this procedure safer, less time consuming and less 
expensive. Moreover, the analysis of multiple regions of interest (ROI) provides flow 
information from various subsegments of the coronmy artery tree, which is not possible or 
more time consuming with other invasive techniques. 
In the setting of pharmacological or mechanical interventions, where the results have to 
be estimated directly after the catheterization, these on-line assessment techniques of 
coronary flow reserve are velY usefuF'. Off-line assessment of CFR, on the other hand, 
allows objective evaluation of multicenter trials in core laboratories, where the selection of 
ROJ's can be carried out by an independent analyst, thereby non-biased by the investigator. 
However, only on-line assessments of CFR have been validated in animal experiments as 
well as in a clinical setting using flow calculations from simultaneously intravascular 
Doppler velocity measurements as a reference ll ,!2. 
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ON·LINE AND OFF·LINE ASSESSMENT OF CORONARY FLOW 
RESERVE 
To assess coronaty flow reserve by videodensitomehy, a fixed amount of non-ionic 
contrast medium is injected at 37~C into the coronary artery using an ECG-triggered 
infusion pump. The injection rate of the contrast medium is judged to be adequate when 
back flow of contrast medium into the aorta occurs. The heart is atrially paced at a level 
approximately 10 beats/minute above spontaneous heart rate. The X-ray exposure per frame 
is kept constant by selecting the lock-in mode on the X-ray generator. After intracoronary 
administration of2 mg isosorbide dinitrate, basal coronalY angiography is performed. Thirty 
seconds after pharmacologically induced maximal hyperemia. using an illtracoronary bolus 
injection of 12.5 mg papaverine, the angiogram is repeated. 
Off·line 
Coronary flow reserve measurement with digital subtraction cineangiography from 35 
mm cinefilm has been implemented in the Thoraxcenter research version of the 
Cardiovascular Angiography Analysis System (CAAS),. Thereby, five end-diastolic 
cineframes are selected from successive cardiac cycles. Logarithmic non-magnified mask-
mode background subtraction is applied to the image subset to eliminate nOB-contrast· 
medium densities, using the last end-diastolic frame prior to contrast administration as a 
mask. The principle of mask mode subtraction techniques allO\vs the determination of 
myocardial time-density curves before and during coronary vasodilatation. In the CAAS 
system at the Thoraxcenter, the appearance-time-contrast density approach, according to 
Vogel et alY, is used. From the sequence ofbackgroulld subtracted images, a contrast arrival 
tinle image is automatically determined, using an empirically derived fixed density 
threshold7• Each pixel is labelled with the sequence number of the cardiac cycle in which the 
pixel intensity level exceeds the threshold, starting from the beginning of the ECG·triggered 
contrast injection. Arrival time numbers are displayed color coded in the CAAS. In addition 
to the contrast an-ivaI time image, a density image is computed! with each pixel intensity 
value being representative for the maximal local contrast medium accumulation. 
On corresponding basal and hyperemic end-diastolic frame sequences, identical regions 
of interest (ROl) are selected in such a way that the epicardial coronary arteries visible on 
the angiogram, the coronary sinus and the great cardiac vein are excluded from the analysis. 
For the calculation of relative blood flow within these regions of interest two parameters 
are required: the relative regional vascular volume and the mean contrast appearance time. 
The relative regional vascular volume can be calculated from the maximal density image, 
the intensity value being proportional to the transradiated amount of contrast medium within 
the vessel. Therefore, the regional vascular volume for a user-defined ROI is proportional to 
the mean radiographic density within the ROl. The mean contrast appearance time is derived 
from the contrast arrival time image. 
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Regional flow values are quantitatively determined using the following 
videodensitometric principle: Q=vrr (Q=regional blood flow, V=regional volume and 
T=mean appearance time). 
The coronary flow reserve for one ROI is then calculated as follows: 
CFR= Qo Vo/To VoX Th OoX Th 
(D=mean maximum contrast density; h=hyperemic; b=baseline) 
On-line 
The on-line method as implemented in the Philips Digital Cardiac Imaging System 
(DCI) uses the same basic principle as the off-line method. After manual selection of the 
mask, the computer automatically determines the end-diastolic images. Interaction by the 
analyst is possible according to visual inspection and the ECG recording. After 
logarithmical transformation of the data, the mask image is subtracted from the subsequent 
images. Usually 5 to 8 of these images are necessary to perform the calculations. From these 
sequences 3 parametric images are constructed: 
A contrast arrival time image (T.",), where each pixel is related to the cardiac cycle in 
which the maximal change in density of contrast is achieved. 
A contrast density image (D=~), where each pixel intensity value is representative for the 
maximal value for contrast density in the sequence of subtracted images. 
Finally, a parametric flow image is constructed, in which the contrast density is divided 
by the arrival time. 
\Vhell parametric images are obtained under baseline and hyperemic conditions, a fourth 
image, a CFR image, can be obtained by exactly superimposing both images, in which each 
pixel intensity value is representative for the calculated CFR. This is performed by the 
computer, but can also be corrected by the analyst, using anatomical landmarks. Gray 
scaling allows quick inspection of the CFR in different areas of the myocardium. 
THE THORAX CENTER EXPERIENCE 
At the Thoraxcenter a study has been initiated to compare, in a clinical setting, off-line 
assessment of CFR, using the cinefilm based analysis system, which is implemented in the 
Cardiovascular Angiography Analysis System (CAAS, digital matrix 512 x 512) with the 
corresponding on-line software, which is implemented in the Phillips Digital Cardiac 
Imaging System (DCI, pixel matrix 512 x 512). 
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Patients 
Elective heart catheterization is performed in all cardiac transplant recipients as part of 
their anllual follow-up protocol. Tills procedure consists of right ventricular biopsy, 
selective coronary angiography and assessment of CFR off-1ine. Since the Del system has 
been installed at the Thoraxcenter, 18 patients (age 46 ± 14, mean ± SD) were included in 
this comparative study. The mean interval after transplantation was 3.2 ± 1.1 year. All 
patients were free of acute rejection at the time of the procedure. They were investigated 
without premedication and their anti-hypertensive medication was discontinued the evening 
before the catheterization. 
Methods 
On- and off-line measurements of CFR were performed as described. Simultaneous 
videocamera acquisition and cinefilm exposure was made possible by selecti.ng the CINE-
DCI mode, usi.ng a standard partially transmitting silver mirror. A print-out was made of the 
on-line CFR image with the selected regions of interest, to allow off-line assessment ofCFR 
in the same areas, using anatomical landmarks (Figure 1). 
To assess left ventricular function, left ventricular angiography was performed in 60" left 
anterior oblique and 30" right anterior oblique projection. Left ventricular ejection fraction· 
(EF) was calculated by the Dodge techn.ique14, and regional wall motion was assessed llsing 
the "Centerline-method", as described by Sheehan, using fractional shortening in 100 
chords, perpendicular to a centerline drawn between the end-diastolic and end systolic 
contours of a ventriculogra1l115• 
Figure 1. Illustration of the image acquisition in this study in it 58 year old male heart transplant 
recipient. Left: On-line assessment of CFR. Right: Off-line assessment of CFR. 
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Figure 2. Results of comparison of digital and cinefilm measurements: The CFR results of the DCI 
are plotted against the results obtained by the CAAS system. The results of the linear regression 
analysis and the line of identity arc included in the graph. 
Statistical methods 
Statistical analysis was performed using lincar regression analysis and the Student's T 
test and \Vilcoxon :Matched-pairs Signed-ranks test for paired analysis. To assess the 
agreement between both measurements, the individual differences between CFR measured 
by CAAS and DCI were plotted against individual mean values, according to the statistical 
approach proposed by Altman and Bland". Mean value and standard deviation of the signed 
differences in CPR between both methods were then calculated. Statistical significance was 
defined as a p value of 0.05 or less. 
Results 
In 18 cardiac transplant recipients a total of 68 ROT's (3.7 per patient, range 3-6) were 
analyzed with both techniques. All patients had a normal left ventricular function with 
normal regional wall motion. Ejection fraction could be assessed in 17 patients and gave a 
mean value of 69 ± 7% .. Mean systolic blood pressure at the time of hyperaemia was 
119 ± 15 mmHg and mean diastolic blood pressure was 84 ± II 1l1lnHg. 
Among the patients included in this study. there was no angiographic evidence of 
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Figure 3. Comparison of digital and cinefilm measurements according to the method of Altman and 
Bland l6 ; The differences between DCI and CAAS measurements are plotted against the mean values. 
The mean difference and 2-fold standard deviation are shown in the figure. 
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Figure S. Comparison of digital and cinefilm measurements according to the method of Altman and 
Bland'6, excluding 2 patients with high values for eFR as assessed by the CAAS system. 
collateral circulation or flow limiting stenosis (>50% diameter reduction) by either visual 
assessment or quantitative analysis. using automated edge detection. 
The linear regression analysis, as shown in figure 2, revealed a reasonable conciatioll 
between CFR measurements using the DCI and CAAS system (r=0.88. y = -0.17 + 1.19 x, 
SEE = 0.81). However, the CAAS measurements (mean 2.62 ± 1.70) were significantly 
higher than the DCI measurements (mean 2.33 ± 1.25) (p = 0.0 I, Wilcoxon Matched-pairs 
Signed-ranks test). According to the approach of Altman and Bland, as showll in figure 3, 
the mean difference between both methods was 0.28 ± 0.84. 
As illustrated by figure 2, the difference between the results of on- and off-line 
measurements is more pronounced for high values of CPR (> 5,0 by CAAS; 6 ROT data 
points). These datapoints were derived from 2 patients only. In one of these patients the level 
of inspiration during the basal and hyperemic coronary angiogram was not identical. 
Therefore the position of the diaphragm could have influenced the result of CFR 
measurements. In the second patient the injection of contrast medium was performed 
selectively in de circumflex artery. 
After exclusion of these 2 patients from the analysis, the relationship between off-line 
and on-line assessment of CPR improved (r = 0.82, Y = 0.37 + 0.88 x, SEE = 0.56), as 
shown in figure 4. There was no significant difference between the results of both 
measurements. The mean value for off-line measurements was 2.26 ± 0.97, for the DCI 
ystem 2.15 ± 0.91. The mean difference between both methods was 0.11 ± 0.56 (Figure 5). 
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DISCUSSION 
During the last decade several studies have demonstrated that the functional significance 
of a coronary obstruction cannot always completely be evaluated by visual interpretation of 
stenosis morphology Of quantitative measurement of it's geometric dimension17,IS, As already 
stated in this book, additional assessment of myocardial blood flow provides better insight 
in the functional significance of a coronmy stenosis. 
Furthermore, assessment of CFR provides information concerning the specific 
characteristics of myocardial pelfusion in patients with cardiomyopathy, syndrome X and 
diffuse coronary artery disease, as present in cardiac transplant recipients. The influence of 
different treatment strategies can be assessed by multicenter trials, where analyses are 
performed in an independent core laboratory, blinded for treatment and therapy. 
The introduction of digitized facilities in the catheterization laboratories made it possible 
to pelform on-line videodensitometric CFR measurements. However, since to date only 5% 
of the European catheterization laboratories (estimation by the industry) are equipped with 
digital angiographic facilities, there is a need for off-line analysis systems based on 
conventional cinefilm. Furthermore, the storage capacity for digital images, which is 
important for the transfer of the digital information to a core-laboratory, is still limited. 
Animal experiments and in vivo validation studies of videodensitometric CFR 
measurements on myocardial regions of interest have shown excellent results J2•J9 • The 
validation using intravascular Doppler assessment of blood flow velocity is eminently 
relevant because the methodological approach of both techniques is completely different. In 
a study of 21 patients undergoing elective PTCA for angina pectoris20 , the CFR 
measurements using off-line digital subtraction cineangiography (OLDSC) were compared 
with CFR measurements using intracoronmy blood flow velocity assessed by a Doppler 
ballooncatheter (DOP). There was a good relationship between the measurements, 
inespective whether the flow was limited by the severity of the stenosis (OLDSC = 0.88 
DOP + 0.12, r = 0.85, SEE = 0.38) only, or whether additional factors were present with 
potential influence on the outcome of CFR measurements like left ventricular hypertrophy 
or coronary artery dissection (OLDSC = 0.96 DOP + 0.01, r = 0.87, SEE = 0.34). 
Animal experiments using microspheres show that despite the possible error sources, 
there is a good correlation between videodensitometric measurements of CPR and the 
application of microspheres (N = 86, r = 0.79, Y = 0.58 + 0.81 x, SEE = 0.80)". 
Since the analysis of the cineangiogram includes the selection of ROJ's in the end-
diastolic images, and the boundaries are drawn by the observer using a writing tablet, 
interfaced with the computer, tltis procedure can introduce some interobserver variability. 
However, as shown in table 1, both the inter- and intra-observer variabilities, as well as the 
short-, medium-, and long-term variabilities of CPR shm\' a reasonable reproducibility of 
this technique20• Interobserver variability from 2 observers, measured in 12 regions of 
interest in 7 patients, was 0.08 ± 0.52 and intraobserver variability, measured in 11 regions 
of interest in 6 patients, was -0.01 ± 0.07. The short-term variability, based on the analysis 
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Table 1. 
Intra-observer 
Inter-observer 
Short-term 
Medium-term 
Long -term 
Reproducibility of the digital sebstraction technique". 
-0.001 ± 0.007 
0.08 ± 0.52 
-0.02 ± 0.26 
-0.06 ± 0.52 
0.11 ± 0.63 
NS 
NS 
NS 
NS 
NS 
of 2 coronruy angiograms made 5 minutes apart and including 13 regions of interest, was 
-0.02 ± 0.26, the medium-term variability, based on repeated coronary cineallgiograms 
within 1-3 hours, was found to be -0.06 ± 0.52 and the long-term variability from repeated 
coronary cineangiograms within 3 - 5 months, was 0.11 ± 0.63. In all these variability 
studies, no significant difference was found between both measurements. 
To assess the relation between CFR, measured by digital subtraction technique, and the 
severity of coronary artelY disease, assessed by quantitative coronary angiography, a 
precision study from the Thoraxcenter on 17 patients with single vessel coronary artery 
disease, and 12 patients with normal coronary artery dimensions, showed a good relation 
between CPR and the minimal luminal cross-sectional area (r ~ 0.92, SEE ~ 0.73) as well 
as between CPR and the percent area stenosis (r ~ 0.92, SEE ~ 0.74)'. In visually normal 
coronary arteries a CPR of 5.0 ± 0.8 was calculated, which differed significantly from CPR 
of the coronary arteries with obstructive disease providing values between 0.5 and 3.9. In 
both tins study as in later studies '9,21 a normal CFR was defined as greater or equal to 3.4 (2 
SD below the mean CFR of angiographically normal coronaty mteries). 
In this study the mean value of the measured CFR is 2.33 ± 1.25 by DCI, and 2.62 ± 1.70 
by CAAS. The distribution of the ROI over the myocarditul1, using the coronary tree as a 
reference, is shown in figure 6. As can be appreciated from this scheme, only in a small 
percentage of ROJ's a normal CPR is measured, wInch is not an unexpected finding in such 
a group of patients2 !. 
The results of this study show that where estimated CFR was ';5.0, a good correlation 
was found between the CPR measurements using both systems. However, where estimated 
CFR was >5.0 by CAAS, the DCI yielded lower CFR values. There me a few possible 
reasons for discrepancy between the methods. First of all, the relation between the local 
amount of contrast and the resulting video brightness, has a different sign for both systems, 
i.e. negative for DCI and positive for CAAS. Despite the applied logarithmic subtraction 
technique, nOll-linear terms may remain in the transfer function between contrast and 
videosignallevel because of non-linear amplification stages in the Del-chain and because 
of the non-linear relation between light exposure of the cine-film and its resulting optical 
transparency. 
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Figure 6. Distribution of the 68 ROI's over the myocardium with reference to the coronary artery 
tree. In bold the percentage of ROJ's having a normal CFR is given. 
Moreover, the fixed density threshold, used in the contrast arrival time image to calculate 
contrast arrival time, is different for both systems. For the off-line system this threshold, 
expressed in percentage of the brightness scale, was empirically derived by analyzing the 
relationship between the baseline and the hyperemic myocardial contrast appearance times 
as well as the resulting CFR in 12 patients with visually normal coronary arteries 7, With a 
low threshold of 4% above video black level and to a lesser extent with a threshold of 8%, 
background density was not eliminated, resulting in very short contrast medium appearance 
times. Therefore, a threshold of 12% was defined for the CAAS system to completely 
exclude the influence of background noise on the calculation of contrast medium appearance 
times. The DCI system uses a threshold of 50% of maximal pixel intensity for the 
calculations of contrast anival time and maximal contrast density in a ROJ. 
Limitations 
Comparing these methods, one has to realize the limitations of this technique. The 
videodensitometric method requires the use of contrast media, which have substantial 
vascular effects, although non-ionic media, like Iopamiro used in this study, may disturb 
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blood flow less than ionic agents I5 .n. Furthermore, because longtenll variability is 
0.11 ± 0.63, this approach is only suitable to detect rather large changes in flow reserve 
(>1.37, mean + 2 SD) and should therefore be used in specific patients, in whom large 
changes of myocardial flow are expected. 
For all techniques, the CFR is based on the ratio between maximal coronalY blood flow 
and resting flow. The latter is mainly determined by the aortic pressure and heart rate, and 
therefore slight changes in these 2 parameters can influence CFR measurements. Flow 
during maximal hyperemia is linearly related to the perfusion pressure. This can result in a 
scatter of CFR data in a single patient. The recently desctibed hyperemic versus perfusion 
pressure relationshipu theoretically overcomes this problem, but is difficult to assess with 
angiography. 
Conclusion 
The digital subtraction technique to measure CFR is a reliable method, which can be 
assessed on-line or off-line. This method is easily applicable, and less time consuming than 
other methods to assess CFR. In view of the good cOlTelation between both the OIl- and off-
line system it is reasonable to propose the use of the off-line technique to assess CFR in 
large multicenter trials where cinefilm is used. The design of the IlREGRESS Il study already 
included these measurements. 
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ABSTRACT 
Accelerated transplant coronary artelY disease is a major impediment of long-term 
survival after cardiac transplantation. In order to evaluate tlus diffuse arteriopathy of the 
coronary artery tree in cardiac transplant recipients, myocardial flow reserve measurements 
(MFR) were performed in 99 cardiac transplant recipients at different postoperative 
intervals. 
Initial measurements were pedormed in 29,17,21 and 32 patients respectively at one 
month and 1, 2 and 3 years after transplantation. 
Serial follow-up measurements of both quantitative coronary angiography and MFR was 
obtained during 77 procedures. The mean MFR in the first postoperative year 2.34 ± 0.82. 
In the following years the mean MFR were 2.16 ± 0.84, 2.63 ± 0.84, 2.43 ± 0.79,2.22 ± 0.83 
and 1.78 ± 0.97 respectively. Only 14 % of the measurements exceeded the normal value of 
MFR (3.4). 
No relation was found with visually detected transplant coronary artery disease and with 
changes in luminal diameter of the large epicardial coronmy arteries as measured by 
quantitative coronary angiography. No immunologic and non-immunologic risk factors for 
accelerated coronmy mtelY disease could be identified. 
Conclusion: :MFR reserve measurements in this group of patients were impaired. No 
significant decrease in the consecutive postoperative years was found. Risk factors for 
changes in individual patients could not be identified. 
INTRODUCTION 
Transplant coronmy artelY disease is one of the limiting factors for long term survival 
after cardiac transplantation I. The earliest change consists of concentric fibrosis and smooth 
muscle cell proliferation with collagen accumulation creating diffuse intimal thickening. 
This is seen as early as one week after transplantation2;J. Subsequently, these lesions may 
progress to diffuse obliterative lesions creating longitudinal narrowing and distal pruning. 
The lesions are generally present in the large epicardial vessels as well as in the small 
intramyocardial branches. To detect the onset and progression of coronary disease in an 
early phase, coronary angiography is performed inmost transplant centers. Three categories 
describing the specific angiographic morphology of the lesions found after transplantation 
are distinguished~: type A, discrete or short tubular stenosis in the proximal, middle or distal 
segments of major coronary arteries or their branches, type B; diffuse concentric luminal 
narrowing in the middle to distal segment branches; and type C, diffusely narrowed irregular 
distal branches that are squared of and end abmptly, the latter two groups both unique to the 
post-transplant patients. 
It has been demonstrated that coronaty angiography is relative insensitive for the 
detection of carly vascular lesions). Both not significant focal lesions « 25% stenosis) and 
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diffuse disease are often underdiagnozed by coronary angiography, even when quantitative 
techniques are used3.:!. 
Myocardial Flow Reserve (MFR) measurements describe the relation between the 
angiographic severity of coronary artery disease and the resulting reduction or limitation in 
maximal blood flow in the myocardium6-IO. Even in the absence of focal atherosclerosis or 
other flow limiting factors in major epicardial vessels, MFR measurements can be used to 
evaluate dysfunction of the microcirculation. This is especially relevant in cardiac transplant 
recipients, where a diffuse arteriopathy can reach a flow limiting significance, without 
changes in angiographic appearancel!,12. 
The purposes of present sttldy were 1) to describe the changes in MFR at different 
postoperative stages up to five years after transplantation, 2) to correlate these changes with 
changes in luminal diameter as assessed by quantitative and visual analysis of the coronary 
angiograms, and 3) to couelate these changes with previously identified risk factors!).2o. 
PATIENTS AND lVIETHODS 
Patients 
The study population consisted of 99 adult heart transplant recipients, who underwent· 
coronary angiography at different postoperative stages, as part of an annual follow-up 
protocoF'. This procedure consisted of right ventricular biopsy, selective coronary 
angiography and assessment of MFR. All patients had undergone orthoptic heart 
transplantation at the Thoraxcenter of the University Hospital Rotterdam, Dijkzigt. In 59 
patients MFR measurements were repeated I and 2 years after the baseline coronary 
angiography thus achieving serial one year and two year follow-up. In 34 patients only one 
year follow-up measurements were obtained. Six patients were lost to foHow-up. 
All patients were treated with standard immunosuppressive regimens, including 
prophylactic anti-lymphocyte antibody therapy during the early postoperative period. 
Maintenance immunosuppressive therapy consisted of low dose steroids and cyclosporine. 
In 12 patients azathioprine was added because of recurrent rejection, 
Cytomegalo virus (CMV) seronegative recipients received anti-CMV immunoglobulin 
(eytotect, Biotest Pharma GmbH, Frankfurt, Germany) during the first 10 weeks after 
transplantation. 
AlI patients were investigated without premedication and their anti-hypertensive 
medication was discontinued the evening before the catheterization. 
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l\1yocar<1ial flow reserve 1l1eaSUrements 
The technique to assess myocardial flow reserve by digital subtraction angiography has 
been extensively described22-28• Coronmy angiography was carried out by femoral approach 
using Judkins technique. An 8 French guiding catheter (Type Judkins, Cordis, Miami, 
Florida, USA) was advanced to the aortic root. To assess myocardial flow reserve, non-ionic 
contrast medium (Iopamiro, Bracco, Italy; 370 mg iodine/ml) was injected at 37~C into the 
left coronary artery using an ECG-ttiggered infusion pump (Medrad IV, Medrad, U.S.A.). 
The hem't was atdally paced at a level approximately 10 beats/minute above spontaneous the 
heart rate, ranging from 90 to 120 beats/min (mean 107 ± II). Filming speed was set at 50 
images per second to obtain equal images in successive cardiac cycles. The X-ray exposure 
per frame was kept constant by selecting the lock-in mode on the X-ray generator. Basal 
coronary angiography was performed in either 90') left anterior oblique or 30~ right anterior 
oblique projection, after intracoronary administration of 2 mg isosorbide-dinitrate. Thirty 
seconds after phannacologically induced maximal hyperaemia, using an intracoronmy bolus 
injection of 12.5 mg papaverine, the angiogram was repeated. 
Myocardial flow reserve measurement with digital subtraction cineangiography from 35 
mm cinefilm has been implemented in the Thoraxcenter Research version of the 
Cardiovascular Angiography Analysis System (CAAS)". Thereby, five end-diastolic 
cineframes are selected from successive cardiac cycles. Logarithmic non-magnified mask-
mode background subtraction is applied to the image subset to eliminate nOll-contrast 
medium densities, using the last end-diastolic frame prior to contrast administration as a 
mask. The principle of mask mode subtr~ction techniques allows the determination of 
myocardial time-density curves before and during coronary vasodilatation. In the CAAS 
system at the Thoraxcenter, the appearance-time-contrast density approach, according to 
Vogel et al!\ is used. From the sequence of background subtracted images, a contrast an-ival 
time image and a density image are automatically determined, using an empirically derived 
fixed density threshold". 
On corresponding basal and hyperaemic end-diastolic frame sequences, identical regions 
of interest (ROI's) are selected in such a way that the epicardial coronary arteries visible on 
the angiogram, the coronary sinus and the great cardiac vein are excluded from the analysis. 
For the calculation of relative blood flow within these regions of interest two parameters are 
required: the relative regional vascular volume and the mean contrast appearance time. The 
relative regional vascular volume can be calculated from the maximal density image, the 
intensity value being proportional to the transradiated amount of contrast medium within the 
vessel. Therefore, the regional vascular volume for a user-defined ROI is proportional to the 
mean radiographic density within the ROI. The mean contrast appearance time is derived 
from the contrast arrival time image, 
Regional relative flow values are quantitatively determined using the following 
videodensitometric principle: Q=vrr (Q=regional blood flow, V=regional volume and 
T=mean appearance time). 
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The MFR for one ROI is then calculated as follows: 
MFR= 
(D:::;mean maximum contrast density; h=hyperaemic; b=baseline) 
The normal value of MFR is defined as greater or equal to 3.4 (2 SD below the mean 
MFR of angiographically normal coronary arteries (5.0 ± 0.8, mean ± SD)". The threshold 
used to assess significant change in 1vIFR was 0.8, which is the standard deviation of the 
measurement as described above. 
Quantitative coronary angiography 
Off-line quantitative analysis was performed using the computer-assisted Cardiovascular 
Angiography Analysis System (CAAS)""'. After conection for pincushion distortion caused 
by the image intensifier, the mean coronary width of each segment was calculated in 
millimetres. The catheter tip or shaft, fIlmed without contrast, was used for calibration. 
The main branch and segments 6, 7, 8, 11 and 13 of the left coronary artery, identified 
by anatomic landmarks, as defined by the American Heart Association33 were selected for 
analysis. All segments were analyzed in two views, preferably orthogonal or separated by at . 
least 30', avoiding foreshortening. 
The "patient global sCOI'e ll provided a description of the coronary status of an individual 
patient, and was defined as the average of the mean widths of the measured segments per 
patient. 
Statistical methods 
Statistical analysis was performed using linear regression analysis. The Shldent's T test 
and Wilcoxon Matched-pairs signed ranks test were used for paired analysis. All data are 
presented as the mean ± SD. Multivariate analysis was pelformed using logistic regression 
to identify variables independently correlated with the changes in MFR. All statistical 
analyses were cal1'ied out with a commercial statistical package (BMDP statistical Software 
Package). P values (two tailed) were considered significant only when less than 0.05. 
RESULTS 
Clinical data 
The baseline characteristics of the patients are shown in table I, There was no difference 
between patients studied at different intervals with respect to mean values of recipicnt- and 
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Table 1. Baseline characteristics 
group A group B group C group 0 
Baseline coronary 
angiography I month 1 year 2 years 3 years 
(timing after HTX) 
Number of patients 29 17 21 32 
Recipient age (yr) t 44 ± 12 47 ±9 43 ± 10 45 ± 10 
Donor age (yr) 26± 8 24±6 25 ±9 23 ±7 
Gender (p/M) 2/27 5112 4117 2/32 
Gender mismatch 8 6 8 12 
HLA-mismatch 
A 1.4 ± 0.6 1.3 ± 0.7 1.3 ± 0.7 1.3 ± 0.6 
B 1.6 ± 0.5 1.5 ± 0.6 1.7 ± 0.5 1.6 ± 0.6 
DR 1.3 ± 0.6 1.6 ± 0.5 1.4 ± 0.7 1.4 ± 0.6 
Immullosuppressive regimen 
- Cyclosporille and 
prednisone (pts) 28 15 17 27 
- Triple therapy (pts) I 2 4 5 
Donor heart ischemia (min) 154 ± 31 163 ± 34 162 ± 44 156 ± 40 
Indication for HTX 13/16 9/8 9112 19/13 
(ischemic/other) 
CMV serology (pos/neg) 16/13 1017 10 III 17/15 
Cholesterol (mmolll) 5.1 ± 1.8 7.2 ± 1.2 7.4 ± 1.9 7.5 ± 1.5 
Triglyceride (mmol/l) 1.3 ± 0.7 2.3 ± 0.7 2.5 ±0.8 2.3 ± 1.0 
HDL-cholesterol (mlllolll) 1.2 ± 1.2 1.4 ± 0.4 1.4 ± 0.5 1.4 ± 0.4 
Use of calcium 
antagonist (pts) 18 15 16 24 
Smoking (pts) 3 0 4 3 
Diabetes Mellitns (pts) 2 
F~female; M~male; CMV~Cytomegalo virus; HDL~High Density Lipoproteins 
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Myocardial flow reserve 
Figure 1. Cummutative curve of the myocardial flow reserve measurements in this group of patients 
(n=158), The normal value of myocardial flow reserve (3.4) is drawn in the figure. 
donor age, gender mismatch, HLA-A+B or HLA-DR mismatch, total serum cholesterol, 
triglyceride, high-density lipoprotein cholesterol levels and the other described risk factors 
for graft atherosclerosis. 
Myocal'dial flow l'esel've 
In this study 243 coronary angiograms were analyzed in 99 patients at different post-
operative intervals. MFR measurements could not be performed in 28 follow-up 
catheterizations because of both clinical and mechanical reasons (arrythmias, total amount 
of contrast already given to the patient and equipment failure). Eighty-five angiograms 
could not be analyzed because of low contrast density after mask mode-subtraction, 
arrythmia's or not identical background subtracted images. 
Table 2 shows the distribution of the results of the MFR measurements in the 
consecutive posttransplant years. Only 14 % of the measurements exceeded the normal 
value of MFR (Figure 1). 
Serial follow-up measurements of both quantitative coronary angiography and MFR was 
obtained during 77 procedures. No correlation was found bet\veen the changes in patient 
global score and MFR with lineal' regression analysis (I' = -1.19, Y = 0.02 - 1.56 x, SEE = 
- 0.18). Subgroup analyses for ROT's in areas of the myocardium perfused by either the left 
anterior descending branch or the circumflex branch of the left coronary artel)', did not 
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Table 2. Myocardial flow reserve measurements at different postoperative intervals. 
Postoperative Myocardial flow reserve Number of measurements 
interval 
1 month 2.34 ± 1.18 23 
1 year 2.16 ± 1.14 29 
2 years 2.63 ± 1.45 35 
3 years 2.43 ± 1.12 38 
4 years 2.22 ± 0.88 25 
5 years 1.78 ± 0.69 8 
Table 3. Decrease in myocardial flow reserve and risk factors * 
Risk factor Patient positive for the Patient negative for the Odds ralio 
risk factor: decrease I total risk faclor: decrease Iioial (95% CI) 
Age recipienl (> 50.2 years) 8/36 12/41 0.64 (0.20102.04) 
Age donor (> 23 years) 10 137 10/40 1.11 (0.3610146) 
Males 13/68 51 9 0.19 (0.2410 0.97) 
Gender mismatch 10/27 10/50 2.35 (0.7310 7.61) 
Nnmber of HLA mismalches (> 4) 7/33 13/44 0.67 (0.20 10 2.07) 
Ischemia oflhe donorheart (> 160 min) 9/36 11/41 0.91 (0.29102.84) 
Indicalion for HTX: IHD 6/36 14/41 0.39 (0.1110 1.28) 
Number of rejeclion episodes (> 0) t 6/17 14/60 1.79 (0.48 10 6.58) 
Smoking 7/22 13/55 LSI (0.44105.10) 
CMY infections 4/l8 16/59 0.77 (0.18 to 105) 
CMY disease 2/7 18170 1.16 (0.52 10 5.49) 
SenUll Choleslerol (> 7.55 mmolll) 13/43 7/34 1.67 (0.52 10 5.49) 
Serum Triglyceride (> 2.26 mmoln) 9/39 11/38 0.74 (0.23 10 2.30) 
Serum HDL·Cholesterol (> 1.29 mmoln) 9/35 11/42 0.98 (0.3110 lOS) 
Use of nifedipine 15156 5121 1.17 (0.3210 4.42) 
Hypertension 5/20 15157 0.93 (0.25 10 3.42) 
" all 77 palienls wilh 1 or 2 year follow-up using 0.8 as a Ihreshold 10 idenlify a signilicanl decrease in 
myocardial flow reserve, IHD=Ischemic Heart Disease; CMY=Cylomegalo I'irus lransplanl; t=during Ihe 
sludy period 
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improve this relation. There was no significant difference between the myocardial flow 
reserve measurements performed at consecutive postoperative intervals (Table 2). 
Statistical analysis using a students t-test could not reveal a correlation between the 
presence of visually detected coronary artery disease of both the epicardial and 
intramyocardial branches of the coronary tree and changes in MFR (p:::::0.48). 
Risk factors 
In contrast with other studies no relation was found bet\veen the occurrence of rejection 
during the catheterization and :MFR.". 
As is shown in Table 3 no risk factors for accelerated coronary artery disease could be 
identified both using univariate analysis and logistic regressionlllodei. A decrease in MFR 
of more than 0.8 was used as a threshold to define the development of diffuse coronary 
artery disease. 
DISCUSSION 
Tlus study was designed to investigate the process of accelerated transplant coronary 
artery disease by measurement of myocardial flow reserve. 
The number of reports concerning the use of myocardial flow reserve to monitor 
transplant coronary artelY disease and identify specific immunologic and non-immunologic 
risk factors for progression of accelerated coronary artery disease, is limited"·12. 
These studies demonstrated that in the absence of allograft rejection, acquired left 
ventricular hypertrophy and regional wall motion abnormalities, myocardial flow reserve 
was normal after cardiac transplantation. During heart rejection episodes the myocardial 
flow reserve was impaired ll • In contrast, in a more recent study, the impairment of 
myocardial flow reserve during cardiac rejection was not demonstrated36• In tlus study mild 
diffuse coronary occlusive disease was associated with a decrease of peak flow response to 
papaverine and thus a decrease of myocardial flow reserve. 
All these studies were performed using intracoronary Doppler. In this study, we lIsed the 
videodensitometric technique instead of coronary Doppler. Since the videodensitometric 
technique can be pelforIned without the insertion of hardware in the coronmy tree, it is more 
applicable in large patient groups. Furthermore, the analysis of the cineangiogram is 
performed off-line, and thus offers an objective method to assess myocardial flow reserveH • 
Validation studies of off-line videodensitometric myocardial flow reserve measurements on 
myocardial regions of interest have shown excellent results compared to intracoronary 
blood flow velocity measurements assessed by a Doppler catheter33• Both the inter- and 
intra-observer variabilities, as well as the short-, medium-, and long-term variabilities of 
myocardial flow reserve show a reasonable reproducibility of this technique39 • 
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The present data show that the myocardial flow reserve in this group of patients is rather 
low. TIlls is somewhat surprising since the incidence of diffuse coronary artery disease is 
limited in this patient group, when assessed by visual or quantitative epicardial coronary 
artery changes21.4o• However, as was already stated in the introduction, coronary angiography 
is relatively insensitive for the detection of early vascular lesions4 ! and dysfunction of the 
small intramyocardial arteries. Therefore, the reduction of myocardial flow reserve in this 
group of patients can be a result of functional damage to the microvasculature. This is in 
agreement with the histologic fIndings of Johnson and coworkers23 willch show smooth 
muscle cell proliferation and accumulation of collagen and ground substance as early as one 
week after transplantation both in large epicardial vessels as in the small myocardial 
branches. 
The exact mechanisms leading to the development of accelerated coronary artery disease 
and the resulting impairment of coronary vascular function are not elucidated. The number 
of HLA-mismatches and the number of rejection episodes are thought to be risk factors for 
the development of accelerated coronary artery disease U -!6. After the initial injury, 
hyperlipidaemia, Cytomegalo virus infections and other risk factors may be a cofactOl-l.5·B.!7. 
20. Unfortunately, ill tills ShIdy no relation was found with previously described risk factors 
for accelerated coronary artery disease (Table 3). Excluding the patients with an acute 
rejection during the catheterization, as assessed by right ventricular myocardial biopsies, did 
not alter these results. A larger number of serial measurements will be necessary to reveal 
the influence of potential risk factors on the function of the microvasculature. 
During allograft rejection, the impairment of myocardial flow reserve is thought to be 
linked to abnormalities of the coronary vasculature. The reversible alteration of myocardial 
flow reserve in these patients can be a result of change in responsiveness of the vascular wall 
to papaverine, compression of intramyocardial vessels as a result of interstitial edema, or the 
release of vasoactive mediators as leukotrienes due to perivascular or intimal lymphocyte 
and monocyte infiItration ll • 
Limitations 
Several potential methodological limitations must be considered when interpreting these 
data. Because myocardial flow reserve depends on the level of basal coronary blood flO\v, 
the smail differences between patients in the different groups could be a result of a higher 
basal myocardial flow due to the high pacing stimulus (mean 107 beats/min) in tlus ShIdy. 
Secondly, myocardial flow reserve measurements may be influenced by pharmacological 
alterations in resting or maximal hyperaeuuc blood flow, despite the fact that intracoronary 
nitroglycerine was administered to obtain maximal epicardial coronary vasodilatation and 
all vasoactive medication was discontinued the evening before the actual catheterization. 
Finally, the number of sequential measurements of myocardial flow reserve in this study is 
low (n~77). 
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Conclusions 
In this group of patients following cardiac transplantation the myocardial flow reserve is 
impaired, probably as a result of stmctural damage to the microvasculature. The myocardial 
flow reserve measurements do not change significantly in the subsequent posttransplant 
years. Therefore, the present data support the earlier findings in patients transplanted at the 
Thoraxcenter in which no overall progression of accelerated coronary artery disease was 
found during long-term follow-up.w. No relation was found between the myocardial flow 
reserve and described risk factors. Visual and quantitative assessment of coronaty artelY 
disease in epicat·dial coronary arteries were not related with changes in myocardial flow 
reserve measurements. Further studies will be necessaty to define the exact role of these 
technologies in the assessment of transplant coronalY attelY disease. More attention should 
be given to vessels of the second and third order. The intracoronary volume measurements 
by videodensitometry offer a new and reliable approach to the assessment of progression 
and regression of coronary altery disease in these vessels·u. Therefore, this technique could 
provide a reliable technique to assess diffuse coronary artery disease in cardiac transplant 
recipients. 
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ABSTRACT 
Previous investigations have used quantitative coronary angiography (QCA) of major 
epicardial vessels to monitor progression of transplant coronary disease, a vasculopathy 
potentially involving the coronary microvasculature. The physiologic significance of these 
changes, however, is uncertain. Therefore, 91 patients without focal angiographic stenosis 
>50% undenvent initial evaluation I month to 5 years after cardiac transplant with 1 year 
follow-up. QCA and rapid atrial pacing to matched maximum heart rate were pelfonned 
with measurement of left ventricular pressure and pressure-derived parameters (+dP/dt, 
Vmax, Tau) by tip manometry. At follow-up study, mean coronary segment diameter (mil ± 
SE) decreased 30 ± 11 microns (733 segments, p < 0,05), No changes in left ventricular 
systolic Of diastolic parameters at rest or with maximum pacing occUlTed over the J year 
follow-up. Similarly, in two subsets of patients with greater decreases in mean coronary 
segment width (a: I month initial study group, QCA decrease 58 ± 25 microns, p < 0,05; b: 
greater than 220 micron one year QCA decrease in patient mean segment diameter group), 
LVEDP, Tau, +dPfdt, and Vmax remained similar to initial study, 
Therefore, over a one year time interval, left ventricular function remained unchanged at 
rest and with rapid atrial pacing. Detectable changes in epicardial vessel size were not 
associated with changes in the coronary microvasculature sufficient to result in a decrease 
in left ventricular functional reserve as assessed by atrial pacing stress testing. QCA and 
rapid atrial pacing may provide complementalY anatomic and functional assessments of the 
coronary vasculature following cardiac transplant. 
INTRODUCTION 
Transplant coronary disease is the leading cause of mortality in patients surviving greater 
than I year following cardiac transplant l • Angiographic2 and pathologic3 shldies have 
identified that transplant coronary disease can be manifest as a diffuse arteriopathy, 
potentially involving small epicardial or intramyocardial arteries. Even in the absence of 
high grade focal stenoses by coronary angiography, allograft arteriopathy may be 
functionally significant and pathologically characterized by diffuse involvement of 
epicardial and intramyocardial arteries4.5. 
Although visual analysis of coronary angiograms may be adequate for the detection of 
high grade focal coronary artery lesions, quantitative coronary angiography (QCA) of 
epicardial arteries has been proposed as a method to assess patients for the development of 
diffuse arteriopathy following cardiac transplant6J• However, the functional significance of 
decreases in mean coronary segment diameter arc uncertain. 
Rapid atrial pacing is a well characterized method to assess the functional significance 
of coronary artery disease. In previous studies, hemodynamic measurements at peak pacing 
revealed highly significant differences in left ventricular end-diastolic pressure, peak 
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positive rate of isovolumic left ventricular pressure rise (+dP/dt), and calculated maximal 
myocardial velocity of shortening (Vmax) in patients with coronary artery disease as 
compared to controls8. Thus, atrial pacing Illay be useful for functional assessment and 
possible early detection of diffuse arteriopathy involving the entire vasculature of the 
Illyocardium. Therefore, in patients J month to 5 years foHowing cardiac transplant without 
high grade focal angiographic coronary obstmctions, we assessed the effects of QCA-
detected changes in average epicardial arterial lumen diameter on global left ventricular 
function using the atrial pacing stress test over a one year time interval. 
PATIENTS AND METHODS 
Patients 
Ninety seven patients 1 month to 5 years foHowing cardiac transplant underwent initial 
functional assessment. Resting and pacing data from a previous report of 57 patients without 
identifiable coronary disease at the time of catheterization were used as controls8. Transplant 
patients with high grade focal coronary obstructions were excluded from this study since 
they were expected to have myocardial ischemia with atrial pacing on tlus basis alone 
without warning symptoms of angina pectoris. Five patients had significant coronalY artery· 
disease (focal stenosis > 50%) at the time of initial study and one patient had normal 
Table 1. Hemodynamics of cardiac transplant and normal patients at rest. 
Hemodynanuc 
Maeasurement 
Heart Rate (bpm) 
Normal pts. 
68 - 80 
LV peak systolic pressure (mmHg) 114 - 170 
LV end-diastolic pressure (mmHg) 7 - 14 
+ dP/dt (mmHg/sec) 1465 - 2255 
Vmax (s") 
Tau (msec) 
49 - 67 
N.A. 
Transplant pts. 
Baseline I Year 
93 ± 12 92 ± 12 
129 ± 17 133 ± 20 
11 ± 5 12 ± 5 
1791 ± 375 1786 ± 353 
61 ± 11 60± 12 
42± 10 43 ± 9 
Normal patient data is presented as the 67% range of normal control patients described 
previously8. Transplant patient data is presented as mean ± standard error. Bpm ;::; beats 
per minute, LV;::; left ventricle, N.A. ;::; not available, Tau;::; time constant of isovolumic 
relaxation, Vmax = peak velocity of contractile element, + dP/dt = peak rate rise of left 
ventricular pressure. 
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coronary arteries at initial 1 month study but developed severe graft atherosclerosis over the 
next year requiring retransplantation. Results of endomyocardial biopsy were not used to 
exclude patients. The remaining 91 transplant patients were reassessed at one year follow-
up and had the following characteristics: the mean age of recipients was 45 ± 12 years and 
the mean age of their donors was 25 ± 8 years. An average of 4.3 ± 1.1 HLA mismatches 
were present. Patients had an average cholesterol of 285 ± 62 mg/dl. Immunosuppressive 
protocols and other patient population features have been previously described9 • 
Methods 
In the cardiac catheterization laboratory, a left ventricular micromanometer tipped 
pigtail catheter was advanced into the left ventricle from the right femoral artelY. A 
temporary pacing catheter was advanced into the right atrium from the right internal jugular 
vein. The following measurements were made with use of a previously described digital 
analysis systemS,IO: heart rate; left ventricular peak systolic and end-diastolic pressures; the 
maximum frrst time-derivative of left ventricular pressure (+dP/dt); the relation between left 
ventricular (dP/dt)/pressure and pressure linearly extrapolated to pressure = 0 (Ymax, the 
theoretical maximal velocity of the myocardial contractile element); and tau, the simple 
exponential time constant of isovolumic pressure decay. Tau measurements were not 
obtained in the control group. 
Baseline resting left ventricular measurements were made followed by the initiation of 
atrial pacing at a rate slightly above baseline heart rate. Atrial pacing was pelformed with 
20 bpm increments every 3 minutes to AV block or a maximum rate of 180 bpm with repeat 
left ventricular measurements made at each rate. 
Coronary angiography was then performed in the transplant population with non ionic 
contrast (Iopamiro, Bracco, Italy; 370 mg iodine/ml) in multiple orthogonal views 
preceeded by 5 mg sublingual isosorbide dinitrate. Coronary angiogram cine films were 
analyzed off-line by automated edge detection using the computer-based Cardiovascular 
Angiography Analysis System (CAAS) which has been previously described in detail u'''. 
Nine epicardial coronary segments were selected for initial and follow-up measurements: 
American Heart Association classification segments 1-3, 5, 6-8, 11 and 13 or 1412. All 
segments were analyzed in two orthogonal views and the results were averaged per segment. 
Segments showing foreshortening, overlap or inappropriate filling were excluded from the 
analysis. The standard deviation of the CAAS QCA system repeated measurement of 
identical coronary segments was 110 microns. Results are reported as a segment based mean 
coronary segment width ± standard enor of the mean as described by de Fey tel' and 
coworkers13• 
In the transplant patients, the atrial pacing protocol and angiographic projections were 
replicated 1 year after initial study. Identical coronary segments were compared to obtain 
changes in mean segment diameters. 
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Statistical methods 
Hemodynamic data are presented as the Illean ± SD. Rest and matched maximuIll heart 
rate hemodynamic variables were compared at initial and at 1 year follow-up using paired 
Student's t-test. 
RESULTS 
Comparison of hemodynamic measurements folIOllillg transplant to normal controls 
(Table 1 and 2). 
In the transplanted patients, the hemodynamic response to pacing was heterogeneous with 
no identifiable trends for any patient subgroup. Transplant patients had a significantly higher 
resting heart rate of 93 ± 12 bpm as compared to controls (p < 0.05). Other than a higher 
resting heart rate, hemodynamics in this group of transplant patients were similar to controls 
and remained stable over I year. 
Changes in epicardial artery size over 1 year (Figme 1). 
Mean coronary segment width of all patients decreased slightly but with statistical 
significance over the 1 year period of follow-up (p < 0.01). hI the subgroup of patients with· 
Table 2. Hemodynamics of cardiac transplant and normal patients during maximal 
atrial pacing. 
Hemodynamic 
MaeaslIrement 
HeaLt Rate (bpm) 
Normal pts. 
130-170 
LV peak systolic pressure (nunHg) 107 - 136 
LV end-diastolic pressure (mmHg) 1 - 8 
+ dP/dt (mmHg/sec) 1800 - 3200 
Vmax (s·') 
Tau (msec) 
63 - 96 
N.A. 
Transplant pts. 
Baseline I Year 
144 ± 21 144 ± 21 
123 ± 18 128 ± 17 
6±4 6±5 
2225 ± 522 2352 ± 512 
70± 16 74 ± 14 
38 ± 8 38 ±8 
Normal patient data is presented as the 67% range of normal control patients described 
previouslys. Transplant patient data is presented as mean ± standard error. Bpm = beats 
per minute, LV ;::; left ventricle, N.A. = not available. Tau = time constant of isovolumic 
relaxation, Vmax = peak velocity of contractile element, + dP/dt = peak rate rise of left 
ventricular pressure. 
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Figure 1. Comparison of QCA-detccted regression of mean segment diameter measurements from 
baseline to 1 year follow-up in all patients (n = 91) and those studied initially I month post-cardiac 
transplant (n = 22), Error bars represent the standard error of the mean. QCA technique was based 
on mean segment analysis by de Fey tel' et alY. * p < 0.01, t p < 0.02. 
initial studies I month following transplant, changes in mean artery segment size were 
approximately twice that of the entire transplant group (Figure 1: p < 0.02). 
Left ventricular hemodynamics with atrial pacing to maximum matched heart rate 
(Tahle 1 and 2). 
By design, heart rate was increased to a matched 144 ± 21 bpm with pacing at initial and 1 
year follow-up evaluation. With pacing, left ventricular (LV) systolic pressure fell slightly 
as LV end-diastolic pressure decreased by approximately 50% at both times of evaluation. 
Indices of contractility, +dP/dt and Vmax, were similar at rest and maximum pacing over 
the 1 year intervaL Tau, the rate of isovolumic relaxation, was also similar over this time 
period. 
Despite greater changes in mean coronary segment diameter over the first year of 
transplant, no significant changes in resting or rapid pacing left ventricular function were 
seen, although changes were heterogenous for the entire population (Table 3). In addition, 
in 14 patients with >220 micron change in mean coronary segment diameter at 1 year (2x 
standard deviation of QCA-system repeated measurement), no changes in baseline or rapid 
pacing measurements were detected (Table 4). 
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DISCUSSION 
Other than a higher resting heart rate in this group of transplant patients, hemodynamics 
at rest and with rapid atrial pacing were similar to non-transplant controls and remained 
stable over 1 year including subgroups with greater changes in epicardial artel), lumen 
diameter. Neither indices of systolic (+dP/dt, Vmax) or diastolic (LVEDP, Tau) function 
were affected over this time period. Thus, in the absence of significant focal stenoses, 
detectable decreases in epicardial vessel lumen size lllay not imply changes in the coronary 
vasculature sufficient to result in a decrease in left ventricular fUllction as assessed by atrial 
pacing stress testing. 
Johnson and coworkers described allograft vasculopathy and other coronary artery 
pathologic changes in transplant patients dying of a variety of causes1\ In patients surviving 
at least 12 months, 15 of 25 showed coronat)' lesions confined to the proximal epicardial 
arteries without involvement of the coronary microvasculature; 10 of 25 exhibited a diffuse 
fibrous intimal thickening with or without atheromatous plaques possibly as a sequela of a 
previous arteritis involving arteries possessing discrete medial layers. The latter subgroup 
was hypothesized to have been subjected to greater myocardial imlllunologic rejection with 
associated inflammation directed toward the coronaty vasculature. 
Quantitative coronary angiography (QCA) has been considered a potentially useful 
method to characterize allograft arteriopathy since pathologicM and intravascular· 
Table 3. Hemodynamics of patients 1 month post-transplant at rest and during 
maximal atrial pacing. 
Hemodynamic Baseline I Year follow-up 
Maeasurement Rest Maximal pacing Rest Maximal pacing 
Heart Rate (bpm) 91 ± 12 151 ± 17 94 ± 13 150 ± 17 
LV peak systolic pressure 
(mmHg) 130 ± 19 114 ± 19 135 ± 28 125 ± 19 
LV end-diastolic pressure 
(nunHg) 13 ± 5 6±4 12 ± 5 5±5 
+ dP/dt (mmHg/sec) 1827 ± 355 2177±485 1734 ± 251 2300 ± 377 
Vmax (S-I) 63 ± II 72±17 58 ± 10 74 ± 12 
Tau (msec) 45 ± 13 42± 10 43 ±8 38 ±9 
N = 22; Patient data is presented as mean ± standard error. Bpm = beats per minute, LV 
= left ventricle, Tau = time constant of isovolumic relaxation, Vmax = peak velocity of 
contractile element, + dP/dt = peak rate rise of left ventricular pressure. 
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Table 4. Hemodynamics at rest and during maximal atrial pacing for >200 Jlm 
diameter reduction group. 
Hemodynamic Baseline 1 Year follow-up 
Maeasurement Rest Maximal pacing Rest Maximal pacing 
Heart Rate (bpm) 93 ± 13 154 ± 15 91 ± 11 154 ± 20 
LV peak systolic pressure 
(mmHg) 123 ± 14 121 ± 14 125 ± 21 126 ± 17 
LV end-diastolic pressure 
(mmHg) 12 ± 5 6±4 12±6 6±5 
+ dP/dt (mmHg/sec) 1764 ± 347 2173 ± 424 1725 ± 270 2345 ± 378 
Vmax (s-') 60± 11 65 ± 18 59 ± 8 74 ± 8 
Tau (msec) 43 ± 10 37 ± 9 41 ± 6 35 ±6 
N = 14; Patient data is presented as mean ± standard error. Bpm = beats per minute, LV 
;:::; left ventricle, Tau;:::; time constant of isovolumic relaxation, Vmax = peak velocity of 
contractile element, + dP/dt ;:::; peak rate rise of left ventricular pressure. 
ultrasound5•15 studies have shown significant diffuse, arterial intimal thickening without 
visllal1y detected focal stenoses by angiography. Furthermore, in evaluating changes in 
epicardial artery diameter, coronary vascular pathology may be underestimated if intimal 
thickening is offset by compensatory or aneurysmal medial dilatation, the so-called "GJagov 
phenomenon"16. Compensatory enlargement, hO\vever, may be less within intramyocardial 
arteries, presumably due to physical myocardial constraints5• Thus, if mean segment 
diameter changes detected within epicardial vessels were manifest diffusely throughout the 
coronary vasculature, increasing oxygen demand could be associated with progressive 
myocardial ischemia affecting left ventricular functional reserve. 
Atrial pacing stress testing has been applied extensively in patients with coronary artery 
disease to measure left ventricular functional reserveS,17.IS, but not previously in patients 
following heart transplantation. 'Vith provoked myocardial ischemia, changes in diastolic 
function may precede changes in systolic function 19• In this study, as in previous studies17•19, 
changes were assessed at peak pacing with heart rates matched at initial and I year foliow-
up. Although pacing may induce changes secondary to ischemia, conditions including left 
ventricular hypertrophy and cardiomyopathy could also be associated with changes in 
systolic or diastolic parameters at rest or at peak pacing2(}. 
The heterogenous results of this study are consistent with the pathologic findings of 
Johnson, et a1. 14 in that transplant coronary disease may be manifest by a spectrum of 
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anatomic involvement and functional changes. Small decreases in proximal epicardial artery 
size may be accompanied by a functional decrease in atrial pacing stress test reserve only 
when associated with significant small vessel coronary disease. Whether rapid atrial pacing 
alone can identify these patients, however, remains unclear. ComplementalY measurements 
of epicardial arterial size, intimal thickness, and reserve to functional stress testing may be 
necessary to fully characterize the manifestations of graft arteriopathy within a given patient 
or group of patients. 
OUf angiographic findings are similar to those of Gao and coworkers from Stanford6 in 
that first year changes in coronaty artelY size were greater than in subsequent years although 
the magnitude of first year change was less in our study. Patients with known 
angiographically significant focal stenoses were excluded for safety reasons from follow-up 
atrial pacing stress testing in this group of patients with denervated hearts. This may in part 
account for the relatively small changes in mean coronaty attery segment size observed in 
this I year follow-up snldy. Even in subgroups with more marked change in epicardial artery 
size, however, no change in myocardial reserve to atrial pacing stress testing could be 
detected. 
Limitations 
Atrial pacing, although llsed for many yeal'S, is not a maximal stimulus for myocardial 
ischemia compared to other stress tests including exercise and dobutamine infusion. 
However, the relative reproducibility and ease of application in the catheterization 
laboratOlY was ideal for testing the functional status of these transplant patients. Thus, 
pacing may be relatively insensitive to small changes in epicardial lumen diameter, but 
could be utilized for functional assessment of patients with focal stenoses or suspected 
vasculopathy involving the entire coronmy vasculature. 
Current methods to diagnose allograft vasculopathy. 
Table 5 lists potential advantages and limitations of the major methods that have been 
applied to the assessment of coronary artery disease in the patient following heart transplant. 
Intravascular ultrasound is the most promising of newer methods that can precisely define 
pathologic changes within the vascular wa1l5.15, but may not yet represent a mature 
technology for obtaining consistent, reproducible circumferential images of the intima-
media intetface throughout the epicardial coronary vasculanJre. Doppler derived coronary 
flow reserve21 should cOlTelate with changes foHowing tachycardic or pharmacologic stress 
but also may be limited due to nonspecific increases in baseline flow associated 
with systemic hypertension or left ventricular hypertrophyn.23. Angioscopy may discriminate 
qualitatively between predominantly fibrous versus fatty plaque as well as thrombus, but 
may not yield quantitative data for compmative studies24• 
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Table 5. Measurements available to assess transplant coronary artery disease. 
Technique 
Visual Angiograllhic Stenosis 
Sizing 
% or minimal lumen diameter by 
angiography. 
Qnantitative Coronary 
Angiography 
Mean width per vessel segment. 
Atrial Pacing Stress Testing 
Intl'3mscular rntrasound 
Lumen diameter and intimal 
thickness 
Corollary Flow Reserve 
By Doppler 
Angioscopy 
Conclusions 
Advantages Limitations 
* Hemodynamic significance can * Does nog detect diffuse 
be assessed by conl'entional changes. 
criteria. 
'" Defines lesions amendable to 
intervention. 
* Can detect diffuse changes. 
* Operator independent with good 
reproducibility. 
:;: Assesses potential for ischemia 
throughout coronary 
vasculature. 
'" Detects biologic process within 
epicardial arteries. 
*" Assesses potential for ischemia 
throughout coronary 
vasculature. 
*" Qualitatively characterizes 
endol'ascnlar pathology. 
'" Canllot use as surrogate for 
entire coronary vasculature. 
'" "Otagov phenomenon" may 
affect interpretation, 
* May be affected by non-
coronary cardiac conditions. 
*' Provides only a moderate stress 
of coronary flow reserve. 
*" Imaging still inconsistent in 
visualization of intimal-medial 
interface throughout coronary 
arterial tree. 
* Mal' be affected by non-
coronary cardiac conditions, 
*" Sensitivity unknown, 
*" Not suitable to quantitate 
arterial changes. 
In patients following orthotopic cardiac transplantation, hemodynamics at rest and with 
rapid atrial pacing remain within normal1imits over a 1 year time duration despite suspected 
development of mild coronary allograft vasculopathy, Quantitative corollmy angiography 
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and rapid atrial pacing stress testing assess complementary aspects of allograft vasculopathy 
that may not necessarily be associated. From tlus study, the changes in QCA appear sooner 
and may be a Illore sensitive predictor of epicardial arteriopathy than atrial pacing stress 
testing, although it's role in defining intimal hyperplasia within the intramyocardial arteries 
remains undefined. Further studies will be necessary to define the relative merit of these as 
well as emerging technologies in the complete assessment of the patient with possible 
transplant coronary disease. 
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In most centers, transplant coronary artery disease has become the leading cause of death 
beyond the first 5 years after cardiac transplantation' and up to 79% of the patients have 
evidence of coronary disease on coronary angiograms made after 3 to 5 years2-S• World wide, 
about 40% (33% and 68% in early reports"') of the causes of death beyond the first year after 
cardiac transplantation are related to accelerated coronary artery diseases. In our experience 
of 293 transplanted patients, actuarial survival is higher compared to the overall survival at 
different transplant centers collected by the International society for Heart and Lung 
Transplantation' (Table I), Only 24% of the deaths beyond the first year after transplantation 
were related to coronary artery disease. The most frequent causes of death were rapidly 
progressive malignant lymphoproliferative disease and other forms of cancer (39%, figure 
1). The low incidence of coronalY death after transplantation at our center and the relatively 
higher overalllisk of malignancy may be related to the more intensive immunosuppression 
llsed at our center in case of an acute rejection. A reduction of the immunosuppressive 
regimen might result in a decrease of the incidence of neoplasia, possibly at the cost of a 
higher incidence of transplant coronary artery disease. 
Figure 2 shows the incidence of coronary interventions, myocardial infarction and death 
related to accelerated coronary artelY disease at our center. Retransplantation because of 
severe coronary disease has been performed in several centersS,lO. We have considered this 
procedure since it is the only available therapy available to prolong survival in transplant 
recipients with severe coronary artery dis~ase. However, we have refrained from such 
intervention because of the discouraging survival rates after a second cardiac 
transplantationS and the long waiting time before transplantation because of the increasing 
waiting list. 
Progression of transplant coronary artery disease 
Visual analysis of the coronary angiograms has conflrmed progression of coronary 
Tahle 1. Survival of the first 267 patients transplanted at the Thoraxcenter (June 1984-
May 1996)', compared to the registry of the International Society for Heart 
and Lung Transplantations. 
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lesions in patients transplanted at our center. The prevalence of abnormalities in all coronalY 
branches increased from 34% after I year to 79% after 5 years5• At 5 year follow-up 
coronary angiography 57% of the patients showed abnormal prllnmy and secondalY 
epicardial branches; in 21% of the patients abnormal tertiary branches were seen. Only 11% 
of the patients showed presumed anatomical significant lesions (more than 50% lesions in 
the epicardial branches or abrupt ending I proximal occlusion of tertimy branches ll ), some 
of which might be amendable to PTCA or CABG. In our series PTCA was performed in 9 
patients. Yet,S of these patients died within 3 years after PTCA because of progression of 
caron my artery disease, as is illustrated in chapter 2. 
In this thesis morphological epicardial coronmy artery changes were studied by 
quantitative serial coronary angiography. Progression of focal coronalY disease was found 
in 50% of the patients of whom in 18% a mixed form of progression in some and regression 
in other segments was shown. Regression of focal coronm)' artery disease was seen in 38% 
of the patients. No such changes were apparent in 13% of the patients (chapter 5). The 
"patient global score" was lIsed to quantitatively characterize the progression of diffuse 
coronary artery disease. The measured changes were small in the first 6 years after cardiac 
transplantation (-0.05 - 0.12 1l1111, N=I04 patients) and did not reach statistical significance 
(chapters 3,4 and 5). These changes were smaller in comparison with other studies (chapters 
3-5). Apparently, the changes in patient global score in these studies underestimate the 
severity of the disease, since it is a mean value of 9 segments, particularly if intimal· 
hyperplasia is offset by compensatOlY medial dilatation I1•13, On an individual base, 20% of 
the patients showed progression of diffuse disease (chapter 5, table 5). In contrast, 50% of 
the patients showed progression of focal disease by quantitative coronmy angiography, 
while in 48% of the patients progression of visually detectable accelerated coronalY artery 
disease was found. 
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In addition to the description of morphological epicardial corollmy artelY changes, 
fUllctional measurements were performed using myocardial flow reserve and atrial pacing 
stress testing to quantify the influence of accelerated coronalY artery disease on myocardial 
flow and cardiac fUllction. The measured myocardial flow reserve (MFR) was rather low, 
Only 14% of the measurements exceeded tlie normal value for MFR (Figure I, chapter 7). 
Rapid atrial pacing stress tests revealed that hemodynamic characteristics of the 
transplanted patients at rest and during maximal atrial pacing \vere similar to controls and 
remained stable over one year (chapter 8, tables 1 and 2). Both techniques did not reveal 
overall progression of transplant coronary artelY disease (chapters 7 and 8). 
In spite of the clear progression of focal and visually detected accelerated coronary 
artery disease, no significant changes were seen in the overall patient global score and 
myocardial flow reserve measurements. Histologic studies ah'eady have shown that 
accelerated coronary artery disease is present in all cardiac transplant recipients as a 
heterogeneous phenomenon with variable distribution, morphologic features and 
severitytU'i. Since the risk of coronmy incidents seems to be related to the progression of 
focal disease (chapter 2), the patient global score and myocardial flow reserve 
measurements are probably not suitable to identify the patients at risk for coronary death. 
Comparison ,,1th progression/regression trials 
In tltis thesis only small changes in the mean luminal diameter were found (chapter 5, 
table 4), similar to the results of trials concerning the angiographic progression and 
regression of both focal and diffuse atherosclerosis in patients with coronary artelY disease, 
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who were not transplantedl6-18. For example, in the MAAS trial the influence of the lipid-
modifying dl11g simvastatine on coronary artery disease was studied l8• In the reference group 
a decrease in mean luminal diameter ofO.02mm/year was found. In the treatment group this 
decrease was smaller (0.005 nun/year). In a more recent report in which the results of a 
number of these trials were combined, the decrease in mean luminal diameter was 0.034 
mm/year in the overall reference groupl9. This thesis showed a change in mean luminal 
diameter from the first to the sixth postoperative year of -0.05, -0.01, -0.03, +0.01, +0.05 
and +0.12 llun respectively (chapter 5, table 4). These changes are of the same order of 
magnitude compared to the reference group of large angiographic progression and 
regression trials. Therefore, we could not confirm the accelerated nature of diffuse 
transplant coronary artery disease in comparison with coronary artery disease in not 
transplanted patients. The increase in patient global score in the fifth and sixth postoperative 
year should be interpreted with great caution, since it is an average measurement in only 29 
and 8 patients respectively. 
Risk factol's 
In tlus thesis we tried to identify immunologic and non-immunologic risk factors for 
transplant coronary artery disease. The progression of coronary artery disease was expressed 
by either progression of visually detected coronary artery disease, decrease in patient global . 
score or progression of focal coronalY artery disease as measured by quantitative analysis of 
coronary angiograms, or decrease in myocardial flow reserve. No specific risk factors could 
be identified (chapters 3-5 and 7). The "beneficial effect" of smoking is probably a chance 
tinding (chapter 5). 
Different risk factors as Cytomegalo virus infections, the presence of B-cell antibodies 
or anti-HLA antibodies, the employed immunosuppressive regimen, elevated plasma 
triglycerides and higher donor age, have been suggested in several publications but could 
not be confirmed by others (chapter 2-5). Since the incidences of accelerated transplant 
coronalY artery disease at the different transplant centers are based on various detection 
techniques and concern smailer patient groups, larger multicenter studies or registries 
should be performed to identify specific risk factors and investigate the influence of 
different treatment protocols on the process of accelerated coronary artery disease. 
PreYelltioll of accelerated coronary artery disease 
One report clearly showed favourable effects of the use of the calcium-channel blocker 
diltiazem on the progression of coronary luminal narrowing in the first postoperative year. 
In the patient group which received no calcium-channel blocker (n=54), a decrease in 
luminal diameter of 0.22 mm was found, whereas luminal diameter did not change in the 
patient group receiving diltiazem (n=52)1°. We used another calcium-channel blocker, 
nifedipine, for the treatment of hypertension in IllOSt patients in our series. It is uncertain 
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whether diltiazem and nifedipine have similar effects in patients with coronary artery 
disease210v• Different and specific receptor sites for verapamil, dihydropyridines (nifedipine 
and nicardipine) and diltiazem have been identified on the cell surface, selectively binding 
these drugs. Verapamil enhances the receptor dependent uptake and metabolism of LDL 
cholesterol in arterial smooth muscle cells in vitro2-1. Nifedipine raises intracellular 
cholesterol hydrolysis and thus reduces cholesterol in lipid-laden cultured smooth muscle 
cellsL\ Furthermore, anti proliferative effects and a reduction in cell migration have been 
described". A lowering of total and LDL cholesterol has been described using diltiazem". 
Further studies are necessary to verify whether these findings are mutual characteristics of 
all calcium-channel blockers or specific properties of individual drugs. 
Recently, the use of calcium-channel blockers has been the issue of much controversy, 
since the analysis of different trials and meta-analyses have shown contradictOlY results with 
regard to safety and efficacy of these drugs2so.J.O. Review of data of clinical trials has raised 
concern as to whether some or all of the calcium-channel blockers could increase the risk of 
infarction and mortality. Due to the great variation in the design of these studies with regard 
to patient selection, duration of treatment and follow-up, and end-points, it remains unclear 
whether the positive effect of nifedipine on coronary artery disease influences the 
cardiovascular mortality, or whether the use of nifedipine is associated with an increase of 
aU-cause mortality31. For example, in the INTACT trial a 28% reduction of new coronruy 
lesions (0.59 lesions per patient in the treatment group versus 0.82 lesions in the placebo 
group) was found with an excess of 6 cardiovascular deaths among 214 patients treated with 
nifedipine (2.8%). Although we did not find a relation between the incidence of transplant 
coronary artery disease and the lise of the cakium-channel blocker nifedipine in our patient 
group (chapters 3 and 5), the supposed anti-atherogenic effects of calcium-channel blockers 
can be useful to inhibit the progression of transplant coronary artery disease. 
Since it has been suggested that immune-mediated phenomena may play an important 
role in the pathogenesis of accelerated coronary artery disease, the exact pathophysiology of 
the effect of calcium-channel blockers especially in cardiac transplant recipients remains 
unclear. Lruoger prospective randomized trials are necessary to determine the specific 
differences between the calcium-channel blockers with regard to their effect on accelerated 
coronmy artery disease. 
The lipid levels after cardiac transplantation are often elevated32• In our series more than 
70% of the patients have a serum cholesterol above 6.5 nUlloUI (chapter 5, table 2). Since 
angiographic progression/regression trials have shown beneficial effects of lipid lowering 
strategies in patients with coronru-y artery disease l6-19, the influence of a HMG-CoA 
reductase inhibitor, pravastatine, on the progression of coronary disease has been studied in 
cardiac transplant recipients (n=97)330 The pravastatine group showed less progression of 
maximal intimal thickness in the first postoperative year (-0.11 ± 0.09 mm v. 0.23 ± 0.16 
mm, p=0.002). This effect may be a result of a decrease of the level of serum low-density 
lipoproteins (LDL) and therefore a reduction of LDL-bound cyclosporin, leaving a higher 
level of free cyc1osporin3.\. Yet, in our studies we could not identify elevated lipid levels as 
CHAPTER 9 125 
a risk factor for accelerated coronary artery disease. In addition to the effects of pravastatine 
on plasma LDL concentrations, other mechanisms may result in a beneficial effect of this 
drug35• Intravascular ultrasound was used to assess the progression of coronary artery 
disease in the cardiac transplant recipients versus angiography in patients with coronary 
artery disease. Since intravascular ultrasound studies vessel wall morphology and pathology 
beneath the endothelial surface whereas angiography studies the effect of atherosclerosis on 
the vascular lumen, a direct comparison between the study in cardiac transplant recipients 
and the angiographic progression and regression trials in patients with coronary artery 
disease is not possible. Yet, lipid-modifying strategies offer potential to reduce the 
progression of accelerated coronary artery disease. 
Detection of tl'ansplant coronary artel'Y disease, which technique to use? 
In view of the above, a reliable assessment technique able to detect transplant coronat)' 
artel), disease in an early phase, and progression over time, is needed to evaluate both the 
origin of this process and the effects of different treatment strategies. 
The application of quantitative coronary angiography for the assessment of accelerated 
transplant coronal)' artery disease in epicardial coronal), arteries is a reliable and easily 
applicable technique36• It is hampered by the fact that it's role in defining arteria-sclerosis in 
the small intramyocardial vessels is limited. Furthermore, this technique only assesses the· 
intimal hyperplasia in the epicardial vessels by it's effect on luminal diameter. 
:Myocardial flow reserve can describe the physiological significance of transplant 
coronary artery disease. The number of reports describing the use of this technique in 
cardiac transplant recipients is limited373 \ Myocardial flow reserve measurements can be 
performed both on-line and off-line (chapter 6), Several potential methodological 
limitations must be considered. First of all, the small differences between patients in the 
different groups in our studies can be a result of a higher basal myocardial flow due to the 
higb pacing stimulus (in our studies: mean 107 beats/min), Secondly, the MFR 
measurements can be influenced by the presence of visually not detected coronary tlstula as 
a result of the large number of ventricular biopsies, performed to monitor rejection. Finally, 
MFR measurements may be influenced by pharmacological alterations in resting or 
maximal hyperaemic blood flow, despite the fact that intracoronat)' nitroglycerine is 
administered to obtain maximal epicardial coronary vasodilatation and all vasoactive 
medication was discontinued before the actual catheterization. The development of smaller 
Doppler devices and combined flow velocity and pressure gradient measurements offer 
potential to improve this technique39 • .w. 
Rapid atrial pacing is a well characterized method to assess the functional significance 
of coronary artery disease~'A2 and may be useful for functional assessment and possible early 
detection of diffuse arteriopathy after cardiac transplantation. The application of tlus 
technique in cardiac transplant recipients has not been described earlier. The changes in 
epicardial coronary artery size may be accompanied by a functional decrease in atrial pacing 
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stress test reserve, only when associated with significant changes in the small 
intramyocardial branches. Despite the low MFR measured in our group of patients, 
indicating significant disease of the intramyocardial vessels, the hemodynamics at rest and 
with rapid atrial pacing were similar to non-transplant controls and remained stable over 1 
year, including subgroups with greater changes in epicardial luminal diameter. Therefore, 
the value of the atrial pacing stress test to detect the onset or progression of transplant 
coronary artery disease remains unclear. 
Recent publications have shown the ability of intravascular ultrasound to image the 
coronary artery in cross section, delineate vessel wall morphology and quantitate intimal 
thickness in cardiac transplant recipientsH -46. The early studies demonstrated a good 
reproducibility and feasibility of this technique31. The 111iniahlrization of the ultrasound 
catheters have permitted application of these techniques during diagnostic procedures in 
smaller vessels. Since the remodelling capacity of the vessel wall can make coronary artery 
disease angiographically undetectable in the early phases of the development of focal 
lesions47 , intravascular ultrasound offers potential for the assessment of accelerated coronary 
artery disease in an early phase. 
Several shldies have confirmed the prognostic importance of the measurement of intimal 
thickening in cardiac transplant recipients-l5.~. For example, mean intimal thickness of >0.3 
mm was associated with a significantly worse 4 year actuarial and cardiac survivaP5. This 
specific study was petformed in 145 heart transplant recipients during routine coronary 
angiography 1 to 10 years after transplantation. However, conflicting data exist about the 
association of immunologic and non-immunologic risk factors and the severity of intimal 
th.ickening~5.-Is. Although intravascular ultrasound offers distinct advantages over routine 
coronaty angiography with regard to characterize changes in wall thickness, larger shldies 
in a higher number of patients are necessary. 
At our center we use the visual analysis of the coronat')' angiograms after the first 
postoperative year for clinical practice. Since there is evidence that the development of 
transplant coronary artery disease is related to events occurring in the first year after 
transplantatioll20·w, we now repeat coronmy angiography after one or two years in patients 
with visual evidence of accelerated coronary artery disease on their first year coronary 
angiogram. In patients with normal epicardial branches 1 year after transplantation, follow-
up angiography is postponed until the fourth post-operative year. 99;nTc methoxyisobutyl 
isonitrile (MIBI) perfusion scintigraphy is applied in patients with anatomical significant 
abnormalities to evaluate reversible ischemia of myocardium and thus the necessity of a 
coronary intervention. 
Because the development of transplant coronary artery disease is related to the changes 
in the first postoperative year, a trial assessing the extend of coronary artery disease in the 
first postoperative year and at later postoperative intervals by intravascular ultrasound and 
coronary angiography would be useful to elucidate the development of this disease. 
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CONCLUSIONS 
The detection and progression of transplant coronmy artery disease has been the focus 
of this thesis. A prospective 2 year follow-up study in cardiac transplant recipients was 
designed to obtain a complete pattern of morphological and functional changes of the 
coronary artery tree during the first 6 years after cardiac transplantation. Long-term yearly 
follow-up angiographic studies in a large number of patients are hampered by the 
development of severe impairment of renal function due to the prolonged use of cyclosporill 
in many patients50, Therefore. our results represent a unique data sct, covering 6 years after 
transplantation. 
Quantitative coronary angiography measurements did not confirm an overall progression 
of accelerated coronary artery disease during long term follO\v~up. We observed a variable 
pattern of changes of both focal and diffuse coronary artelY disease within patients as 
measured by quantitative coronary angiography. Therefore, global measurements in large 
patient groups are not useful to describe the clinical severity of accelerated coronary artery 
disease. The progression of focal disease appeared more useful to identify patients at risk 
for coronary death after cardiac transplantation. Progression was not shown in decrease of 
myocardial flow and function. The additional value of Myocardial Flow Reserve and Atrial 
Pacing Stress measurements to identify the progression of accelerated coronary artery 
disease in the small intramyocardial branches and patients at risk for coronary incidents was . 
not confirmed. 
No specific immunologic and non-imlllunologic risk factors for progression of 
accelerated coronary artery disease could be identified, probably as a result of the slow 
progression of transplant coronary artery disease in the studied group of patients. Therefore, 
no specific recommendations can be made with regard to the peri- and postoperative 
treatment regimen. As described in the literature, the lise of calcium-channel blockers, lipid 
lowering drugs, the prophylactic use of CMV hyperiml11unoglobin and the administration of 
a blood transfusion prior to transplantation, may have contributed to the lllore favourable 
results in our series. 
In comparison with other transplant centers the number of deaths related to accelerated 
coronary motel)' disease is low in our patient group. This is consistent with the small changes 
in coronary diameter found in our studies. 
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SUMMARY 
Chapter 1 
The history of cardiac transplantation is presented as well as the use of different 
diagnostic tools to assess the progression of accelerated coronary artery disease. 
In particular, the application of quantitative coronary angiography, myocardial flow reserve 
measurements and atrial pacing stress test arc described. 
Chapter 2 
Progression of both diffuse and focal coronary artery disease is described in 5 patients. 
Progression of focal coronary artery disease in cardiac transplant recipients appears to be as 
rapid and unpredictable as native coronm)' atherosclerosis. It has an unfavourable outcome, 
which is illustrated in tIus chapter. Four of the described patients died within 3 years after a 
coronary intervention. 
In our series of 293 patients, 9 transplant recipients underwent coronary intervention 
because of a significant stenosis of the coronary artery tree. Polymerase chain reaction 
analysis was performed in a coronary atherosclerosis specimen received by atherectomy in 
one of the patients. The coronary arteriosclerotic tissue of tlus patient showed the same 
alleles as the tissue of the donor. Therefore, focal lesions in cardiac transplant recipients may 
represent progression of preexisting donor heart lesions. 
Chapter 3 
Early changes in coronary luminal diameter may predict the development of accelerated 
coronary artery disease. Therefore the changes in coronary luminal diameter were studied in 
the first year after cardiac transplantation by quantitative coronary angiography in 30 
patients. 
The mean segment diameter of the 249 analyzed segments showed a small but significant 
decrease from 3.40 ± 0.82 nun at one month after transplantation to 3.36 ± 0.83 mill at one 
year. On a patient based patient global score 40% of the patients showed luminal narrowing, 
in 40% coronary luminal diameter did not change, and in 20% an increase in luminal 
diameter was found. These changes \vere small compared to those in a similar report 
concerning 2S patients transplanted in Stanford. In this group of patients a distinct reduction 
of 0.23 ± 0.19 nun was found. 
No risk factors for accelerated coronary artery disease could be identified in our series. 
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Chapter 4 
Serial one year follow-up quantitative coronary angiography was performed in 111 
patients at different postoperative intervals, ranging from 1 month to 5 years after cardiac 
transplantation. The number of rejections and Cytomegalo-virus infections were higher in 
the first postoperative year. There was no significant difference between the groups for other 
immunologic and non-immunologic risk factors for accelerated coronary atherosclerosis. 
In the 5 subgroups with different follow-up intervals 249, 227,173,186 and 75 segments 
were analyzed respectively. The largest change occurred in the first and third postoperative 
year (-0.05 and -0.07 IllIll respectively) and proved to be statistically significant. Patient 
global score did not show significant changes. 
Since serial quantitative coronary angiography can be an objective method to assess the 
incidence of transplant coronary artery disease, larger studies are proposed to investigate the 
influence of different treatment protocols on the process of accelerated coronary artery 
disease. 
Chapter 5 
In 104 patients the changes in coronmy luminal diameter at different postoperative 
intervals were described in a 2 year follow-up study. The progression of both diffuse and 
focal coronary artery disease was evaluated using the patient global score and the minimal 
luminal diameter per segment respectively. 
There \vas a trend towards nalTOWillg of mean diameter in the first 3 years, and widening 
in subsequent yem·s. These changes were not statistically significant. The changes in patient 
global score were equally distributed in patients with and without visual1y detected 
progression of accelerated coronary artelY disease. Progression of focal disease was found 
in 33 patients. Thirty-nine patients showed regression of focal disease. A mixed form was 
found in 19 patients and in 13 patients no changes were seen. 
Not-smoking was identified as an independent predictor of both diffuse and focal 
coronary artelY disease by multivariate analysis using mUltiple logistic regression. This lllay 
be a chance finding. 
Chapter 6 
The concept of coronary flow reserve (CFR) has been developed to evaluate the 
relationship between the angiographic severity of coronmy artery disease and the resulting 
reduction of maximal coronary blood flow in the myocardium. In the absence of focal 
arteriosclerosis these measurements can be used to evaluate dysfunction of the myocardium. 
Since the introduction of digitized facilities in catheterization laboratories CFR can be 
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performed both on- and off-line. 
In 18 cardiac transplant recipients both systems were compared. A total of 68 regions of 
interest (ROJ's) were analyzed using both techniques. The linear regression analysis 
revealed a good correlation between both systems (y = 0.37 + 0.88x, r = 0.82, SEE = 0.56). 
According to the approach of Altman and Bland, the mean difference between the 
measurements performed by both methods was 0.28 ± 0.84. 
The off-line technique can be used to assess CFR in large (multicenter) trials, where 
selection of ROI's can be canied out by an independent analyst. 
Chapter 7 
Myocardial flO\v reserve measurements (MFR) were performed in 99 patients at 
different postoperative intervals to monitor the presence and progression of accelerated 
coronary artery disease. Serial follow-up measurements of both quantitative coronary 
angiography and MFR were obtained during 77 procedures. 
The NIFR in this studied group of patients was low, only 14% of the measurements 
exceeded the normal value of MFR (3.4). No significant decrease was found during long-
term foHow-up. No correlation was found between the changes in patient global score and 
MFR using linear regression analysis (y = 0.02 - 1.44 x, r = -1.75, SEE = -0.18). Subgroup 
analysis for ROJ's in areas of the myocardium perfused by either the left anterior descending 
branch or the circumflex branch of the left coronmy artery, did not improve this relation. 
No relation was found between the presence ot visually detectable coronmy artery 
disease and changes in .MFR (p=O.4S). Risk factors for accelerated coronary artelY disease 
were not identified in a logistic regression model using a decrease in MFR of more than O.S 
as a threshold to define the development of diffuse corollmy artery disease. 
Chapter 8 
Atrial pacing stress tests were studied in 97 patients following cardiac transplantation. 
The hemodynamic measurements at rest and at maximal pacing were heterogeneous with no 
identifiable trends. Only the resting heart rate was higher as compared to controls (93 ± 12 
beats per minute versus 68-S0 beats per minute respectively). 
Neither in patients studied over the first postoperative year 110r in patients with >0.22 
111111 change in patient global score, changes in baseline or rapid pacing hemodynamic 
measurements were detected. 
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Chapter 9 
In our experience only 24% of the deaths beyond the first year after transplantation are 
related to transplant coronmy artery disease. Visual analysis of coronary angiography has 
confirmed progression of coronary lesions at our center. The use of quantitative coronary 
angiography, myocardial flow reserve measurements and atrial pacing stress tests in cardiac 
transplant recipients is discussed. 
Progression of focal coronary disease was found both by quantitative and visual analysis 
of the coronary angiograms. The patient global score was used to describe the progression 
of diffuse disease. The changes in patient global score were small and of the same order of 
magnitude compared to the reference groups in large angiographic progression and 
regression trials. The additional value of MFR measurements and atrial pacing stress tests 
was not shown. Since the risk of coronary events seems to be related to the progression of 
focal disease, the patient global score and MFR measurements are probably not suitable to 
identify the patients at risk for coronary events. Intravascular ultrasound studies offer 
potential to quantitate intimal thickness in cardiac transplant recipients and thus describe the 
progression or regression of accelerated coronary artery disease in more detail in future 
studies. 
No immunologic or non-immunologic risk factors for accelerated coronary artery 
disease could be identified using the described techniques. The use of calcium-channel 
blockers, lipid lowering drugs, the prophylactic use of CMV hyperiullllunoglobin and the 
administration of a blood transfusion prior to transplantation, may all have contributed to the 
more favourable results in our series. 
In view of our results no specific recommendations could be made concerning the 
prevention of accelerated coronary artery disease. Further evaluation in larger patient groups 
remains necessary to verify these findings. 
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Hoofdsluk 1 
Versnelde coronairc atherosclerose is cen van de problemcn die optreden na cell 
orthotope harttransplantatie. In dit hoofdstuk worden verschillcllde methoden (kwantitatieve 
coronaire angiografie. coronaire flow reserve en atrium-pacing-stress-test) beschreven die 
gebruikt kunnen worden om progressie van deze ziekte vast te stellen. 
Hoofdsluk 2 
Progressie vall zowel diffuse als foeale atherosclerose wordt beschreven bij vijf 
patienten. Progressie van focale atherosclerose bij harttransplantatie patiellten Iijkt even snel 
en onvoorspelbaar op te treden als atherosclerose bij niet-getransplanteerde patientcn. De 
ernst van de ziekte wordt ge'illustreerd door de beschrcven paticlltcll. Vier van hen overleden 
biullcn 3 jaar na een eoronaire interventie. 
In Rotterdam zijn inmiddels 293 patienten getrallsplanteerd, waarvan 9 patienten cen 
eoronaire interventie ondergingen wegens een signifieante stenose van een of meer 
kransslagaderen. Bij een van de paticnten werd de herkomst van de gladde spiereellen in een 
primaire coronaire vernauwing onderzocht. De studies werden ven-icht op DNA, dat 
gei'soleerd werd uit een athereetomie fragment. De resultaten van DNA fingerprinting 
bevestigden dat de atherosclerose vaornamelijk bestand uit gladde spiercellen afkomstig 
van de donor. Facale vernauwingen na een harttransplantatie kunnen derhalve ontstaan door 
progressie van reeds bestaande donor atherosclerose. 
Hoofdsluk 3 
De veranderingen van de eoronaire diameter in het eerste post-operatieve jaar werden 
bestudeerd bij 30 patienten, omdat besehreven is dat veranderingen in eoronaire diameter in 
het eerste jaal' na een harttransplantatie de ontwikkeling van versnelde atherosclerose 
zoudell kunnen vaorspellen. 
De gemiddelde diameter van de 249 segmenten was 3.40 ± 0.82 mm een maand l1a 
transplantatie en toonde een geringe doch significante vermindering resulterend in een 
gemiddelde diameter van 3.36 ± 0.83 mm een jaar na transplantatie. Op patient basis (patient 
global score) toonde 40% van de patienten een afname van gemiddelde coronaire diameter. 
Bij 40% van de patienten werd gcen verandering gevonden. Twintig procent van de 
patienten toonde een toename van de eoronaire diameter. 
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In vergelijkillg met cell publikatie nit Stanford waren deze veranderingen klein. Bij 25 
patienten yond deze groep een vermindering van de gemiddelde coronaire diameter van 0.23 
± 0.19 min in het eerste postoperatieve jaar. 
Er werden geen risicofactoren voor versnelde coronaire atherosclerose gevonden. 
Hoofdstllk 4 
Bij III patientell werd seriele l-jam's follow-up kwantitatieve coronair angiografie 
verricht op verschillende tijdstippen l1a de transplantatie. De groepen verschilden onderling 
niet Vaal' wat betreft illllllunologische en niet-immunologische risicofactoren voor versnelde 
coronaire atherosclerose. Het aantal afstotingen en Cytomegalo-vil1ls infecties was, zoals 
verwacht, hoger in het eerste post-operatieve jaar. 
In de 5 verschillende subgroepen werden respectievelijk 249, 227, 173, 186 en 75 
segmenten geanalyscerd. De grootstc vermindering van coronaire diameter werd in het 
eerste en derde post-operatieve jaar gevonden (respectievelijk -0.05 en -0.07 mm). Deze 
veranderingen blekell statistisch significant. Op patient basis werden tijdens de 
studieperiode geen verallderingen in coronaire diameter gevollden. 
Geconcludeerd werd dat grotere studies noodzakeJijk zijn om met behulp van 
kwantitatieve coronair angiografie de invloed van verschillende behandelingsprotocollen op . 
het proces van versnelde coronaire atherosclerose vast te stellen. 
Hoofdstllk 5 
Een twee-jadge foHow-up studie, waarin de verandering in coronaire diameter op 
verschillende post-operatieve tijdsintervallen werd beschreven, werd uitgevoerd bij 104 
pati1::nten. De progressie van diffuse coronaire atherosclerose werd onderzocht door middel 
van de "patient global score". Progressie van focale eoronaire atherosclerose werd 
onderzocht door gebruik te maken van de minimale coronaire segment diameter. 
Deze studie toonde een trent waarbij de gemiddelde diameter in de eerste drie jaren na 
transplantatie eell afname vertoonde. In de daarop volgellde jaren werd een niet-significante 
toename gevonden. De individuele veranderingen in eoronaire diameter waren gelijkelijk 
verdeeld over patiellten met en zonder visucle toename van coronaire atherosclerose. 
Progressie van foe ale ziekte werd gevonden bij 33 patienten. Regressie werd gevonden bij 
39 patienten. Negentien patienten toonden enerzijds progressie ell anderzijds regressie in 
verschillende segmenten. Bij 13 patienten werden geen veranderingcl1 gevonden. 
De toename van zowel foeale als diffuse coronaire atherosclerose bleek gereIateerd te 
zijn aan het rookgedrag van de individuele patient. Dit is waarsehijnlijk een 
toevaIsbevinding. 
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Hoofdstul< 6 
Bepating van de coronaire doorstromingsreserve is cen techniek die outwikkeld is om de 
relatie tussen de angiografische ernst van de vernauwing van de kransslagaderen en de als 
gevolg dam"van optredende verminderillg van bloeddoorstroming van het myocard te 
beschrijven. Indien geen focale atherosclerose aanwczig is, kan deze techniek worden 
gebruikt om dysfunctie van de capiUaire doorstroming van het myocard te evalueren. Deze 
techniek kan zowel tijdens als na de angiografie worden vcrricht (on-fulc en off-line). 
Een vergelijkende sn,die tussen beide systemen werd verricht bij IS getransplanteerde 
patienten. In totaal 68 regio's van het ruyocard werden geanalyscerd. Lineaire regressie 
analyse toonde een goede relatie tussen beide technieken (y~0.37 + O.SSx, r~0.S2, SEE~0.56). 
Met behulp van de statistische analyse techniek, zoals beschreven door Altman en Bland, 
werd een gemiddeld verschil in de resultaten van beide technieken gevollden van 0.28 ± 0.84. 
Geconcludeerd werd dat de off-line techniek een goede mogelijkheid bied om coronairc 
doorstromingsreserve te bestuderen in grote studies. 
Hoofdstul< 7 
Het proces van versnelde coronaire atherosclerose werd geevalucerd bij 99 patienten 
door middel van coronaire doorstromingsmetingen op verschil1ende tijdsintervallen na een 
harttransplantatie. Volledigc gegevens van zowel seriele kwantitatieve metingen van 
coronaire diameter en coronaire doorstromirigsreserve waren beschikbaar bij 77 procedures. 
De gemiddelde coronaire doorstromingsreserve in de studie groep was laag en er wcrden 
geen significante veranderingen gevonden gcdurende langc tennijn follow up. Er werd geen 
relatie gevondcn tussen de veranderingen in individuele diameter en coronaire 
doorstromingsreserve met behulp van lilleaire regressie analyse (y ~ 0.02 - 1.44x, r~ -1.75, 
SEE = -0.18). Specifieke analyses van de coronaire doorstromingsreservc in zowel het 
doorbloedingsgebied van de LAD als ReX gaven geen verbetering van deze resultatcn. 
Er bleek geen relatie te bestaan tussen de visueel aallwezige vcrsnelde corollaire 
atherosclerose en de resultaten van veranderingen in coronaire doorstromingsreserve. Er 
werden geen risicofactoren voor het ontstaan van versnelde corona ire atherosclerose 
ge'identificeerd. 
Hoofdstui< 8 
Bij 97 patienten werden atrium-pacing-stress testen verricht. De haemodynamische 
metingen toonden een heterogcne verdeling, zowel in rust als bij maximale pacing. In 
vergeJijking met een controlegroep van niet-getransplanteerde patienten werd eell hogerc 
basis hartfrequcntie gezien (respectievelijk 68 - 80 slngen per minuut en 93 ± 12 slagen per 
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minuut). 
Zowel bij patienten waarbij de metingen werden verricht in het eerste post-operatieve 
jaar als bij patienten met een significante vermindering in individuele coronaire diameter 
werden geen veranderingen in haemodynamische metingen vastgesteld. 
Hoofdstuk 9 
Van de mensen die getransplanteerd zijn op het Thoraxcentrum en overlijden langer dan 
I jaar na de transplantatie, overlijdt slechts 24% aan de gevolgen van versnelde coronaire 
atherosclerosc. Visuele beoordeling van de coronair angiogrammen heeft de toename van 
lesies bevestigd. Een vergcJijking wordt gemaakt tussen het gcbruik van kwantitatieve 
coronair angiografie. coronaire flmv reserve en atrium-pacing-stress test. 
Met behulp van visuele analyse en quantitatieve analyse werd een toe name van focale 
lesies gevonden. De veranderingen in "patient globaJ score", ais maat voor diffuse 
atherosclerose waren van dezelfde orde van grootte als de veranderingen die gevonden 
worden in progressie/regressie studies. Coronaire doorbloedingsmetingen en atriale-pacing-
stress testen gaven geen additionele inforInatie. 
Risicofactoren voor versnelde coronaire atherosclerose konden met behulp van ons 
onderzoek niet worden vastgesteld. Het gebruik van calcium-antagonisten. CMV 
antilichamen en pre-operatieve bloedtransfusies l'1ll1nen hebben bijgedragen tot de gUllstige 
resultaten in onze patientengroep. 
In het Hcht van onze resultaten kUllnen geen specifieke aanbevelingen worden verricht 
voor voorkoming van versllelde coronaire atherosclerose. Nadere evaluatie in grotere 
groepen patienten is aan te bevelen am deze bevindingen te verifieren. Intravasculaire 
echografie is mogelijk een nieuwe techniek die de toename van de intima-dikte van de 
coronair arterien beter kan beschrijven. 
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